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Experimental observations implicate the neutrophil in secondary myocardial injury
following myocardial infarction and in reperfusion injury after successful thrarbolysis.
Activated neutrophils can induce local tissue injury through the release of proteolytic
enzymes and via the generation of oxygen derived free radicals, but are also involved in
the no-reflew phenomena seen after reperfusicn. The object of this thesis was therefore
to investigate the role of the neutrophil in myocardial infarction in nan.
A method for studying the neutrophil uptake in damaged myocardium was developed which
allowed rapid separation and subsequent radiolabelling of a "pure" population of
autologous neutrophils using Indium-Ill axine ( In). In-labelled neutrophils
exhibit normal in-vivo kinetics, with rapid lung clearance and migrate to sites of
infection and inflarmaticri and were used to image the acute inflammatory infiltrate in 30
patients with acute infarction. Imaging success was dependent en time of injection of
the cells in relation to onset of symptoms. All patients injected within 18 hours had
positive images whereas less than 50% of patients injected after 24 hours lad positive
images. The use of gamma camera imaging with single photon emission computed tomography
improved imaging and allowed quantification of myocardial uptake of radioisotope. A
subsequent study showed that neutrophil uptake was less extensive, relative to infarct
size (assessed by Ttechnetiun-99m pyrophosphate) in patients treated with thrombolytic
therapy compared to patients not given thrombolysis.
A further study investigated neutrophil activation, by measuring plasma neutrophil
elastase, and free radical production, by measuring the non-peroxide diene conjugated
isomer of linoleic acid (PL-9, 11-IA') in 32 patients with acute myocardial infarction, 30
normal subjects and 35 patients with stable ischaemic heart disease. Neutrophil elastase
was measured using a standard radioimmunoassay and a method established for measuring PL-
9, 11-IA' by high performance liquid chromatography. Samples taken over the 48 hours
following myocardial infarction shewed neutrophil elastase was significantly increased
compared to normals or patients with ischaemic heart disease. Patients not treated with
thrcrrbolytic therapy had a late increase in neutrophil elastase at 40 hours, consistent
with release from activated neutrophils present within injured myocardium. In contrast,
patients treated with thrombolytic therapy had increased levels of neutrophil elastase at
8 hours consistent with intravascular neutrophil activation. Plasm PL-9, 11-LA'was
significantly increased in patients with acute myocardial infarction ccrrpared to normal
subjects or patients with ischaemic heart disease. The levels were similar in patients
treated with and without thrombolytic therapy.
The results confirm neutrophil migration to the site of myocardial infarction with
neutrophil activation and free radical production. However, they do not suggest that
neperfusion is a significant clinical problem, as thrarbo lytic therapy appears to reduce
rather than enhance the acute inflammatory infiltrate and is not associated with a greater
increase in neutrophil activation or free radical production. FUrtlier modification of
the inflammatory response is unlikely to be of benefit following thrombolytic therapy, but
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THE PURPOSE OF THIS THESIS
In most industrialised countries, ischaemic heart disease
is the commonest cause of death, and accounts for
approximately 30% of all deaths in the United Kingdom.
The syndrome of myocardial infarction, though only
recognised as recently as 1912, now represents 15-20
percent of all medical admissions to Edinburgh Royal
Infirmary.
The introduction of coronary care units in the 1960's led
to an improved understanding of the evolution and
complications of acute myocardial infarction, followed by
subsequent improvement of in-hospital mortality by early,
effective treatment of life threatening arrhythmias. The
major problems in coronary care then became severe left
ventricular failure, cardiogenic shock and extension of
infarction. It has now been established that following
myocardial infarction, the main determinant of morbidity
and mortality both in the acute phase and for survivors is
infarct size and associated residual left ventricular
function. This has led to attempts to preserve
myocardial function, particularly using thrombolytic drugs
to recanalise and hence reperfuse the infarct related
coronary artery. Recent studies have shown the clinical
benefit of this therapy which reduces mortality and
preserves ventricular function, particularly in patients
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with anterior myocardial infarction. In general,
coronary care is of most benefit to patients admitted
early as most of the life threatening complications of
myocardial infarction occur in the first hours following
the onset of symptoms. Likewise, thrombolytic therapy
appears to be of greatest benefit whjen administered within
4 hours and preferably within 1 hour of the onset of
symptoms. In practical terms this means that functional
myocardial salvage is most likely to be achieved in
patients admitted early in the course of myocardial
infarction. This means that for many patients only
symptomatic treatment is available.
Despite the increasing clinical evidence showing the
beneficial effects of thrombolysis, there is considerable
experimental evidence which suggests that the restoration
of a blood supply to an ischaemic area of myocardium may
cause the death of irreversibly injured myocytes,
so-called reperfusion injury. Reperfusion produces a
complex group of phenomena some of which have been
implicated in accelerating myocardial damage. These
include the no-reflow phenomenon which is largely due to
capillary plugging by neutrophils, calcium influx, the
production of oxygen derived free radicals and the release
of proteolytic enzymes from phagocytes. Therefore the
neutrophil, may be an important component of reperfusion
injury, as this cell is involved in the no-reflow
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phenomena, is a major source of proteolytic enzymes and is
capable of generating oxygen free radicals as well as
generating mediators of the inflammatory response.
The neutrophil may also be important in secondary
myocardial injury following acute myocardial infarction in
patients who have not received thrombolytic therapy. In
common with all tissue damage, myocardial infarction
elicits a normal local acute inflammatory response with
early neutrophil migration, at the site of tissue injury.
As such, the neutrophils represent an essential component
of the inflammatory response being necessary for
phagocytosis and removal of necrotic tissue allowing
subsequent tissue remodelling. However, experimental
studies have shown that neutrophil depletion of animals
prior to occlusion of a coronary artery can reduce the
size of the infarct. Thus, it is possible that therapy
designed to regulate the inflammatory response to
myocardial infarction, may improve myocardial salvage in
patients treated with or without thrombolytic agents.
The purpose of this thesis was therefore to examine the
potential role of the inflammatory response and in
particular the neutrophil, in myocardial infarction and
also to study the effect of thrombolytic therapy on this
response. Post mortem and animal studies have shown that
neutrophils are present within the area of myocardial
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necrosis within 24 hours of infarction and continue to
migrate over the next 48-72 hours. This response can be
imaged using radiolabelled autologous neutrophils, which
although normally used to detect sites of occult
infection, have also been used to image acute
inflammation. White cell imaging has been used to detect
the acute inflammatory response at the site of myocardial
infarction in dogs and in one previous study in man, it
was hoped to use this technigue to further study the role
of the neutrophil in myocardial infarction in man. First
it was necessary to establish a method for reliably
separating and radiolabelling a "pure neutrophil"
population from blood obtained from patients with acute
myocardial infarction. After re-injection, the
radiolabelled autologous neutrophils were used to study
the neutrophil uptake at the site of myocardial injury
using conventional gamma camera imaging. Factors which
could potentially influence this response, such as infarct
size and time from onset of symptoms, were also studied.
The extent or volume of uptake of radiolabelled
neutrophils was quantified using single photon emission
computed tomography and compared with infarct size,
assessed by the same method, using the infarct avid
imaging agent Technetium-99m pyrophosphate. The effect
of thrombolytic therapy on the inflammatory infiltrate in
relation to infarct size was studied to assess the effect
of reperfusion.
8
In the second part of the study, two possible mechanisms
by which neutrophils could cause secondary myocardial
injury were investigated. Activated neutrophils release
a number of potent proteolytic enzymes, amongst which is
neutrophil elastase. This enzyme has not only been
implicated in the pathogenesis of a number of diseases,
but can also be measured in plasma, using a sensitive
radioimmunoassay, and provides a useful marker of
neutrophil activation. Plasma neutrophil elastase was
therefore measured in serial blood samples taken from
patients in the first 48 hours of myocardial infarction to
study the extent of neutrophil activation and compared
with the appearance in plasma of the cardiac associated
enzyme creatine kinase.
Another mechanism by which activated neutrophils may
extend myocardial injury is through the release of oxygen
free radicals, though neutrophils are not the only
potential source of free radical production within
ischaemic myocardium. Measuring free radical activity in
vivo is difficult, and the methods are usually indirect,
because of the short biological half-life of microseconds.
The most studied methods measure the auto-oxidation
products of polyunsaturated fatty acids, a process termed
lipid peroxidation or lipid oxidation. These compounds
are commonly used to measure free radical activity, but
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some have also been directly implicated in cellular injury
by producing membrane damage. Recently the non-peroxide
diene conjugated isomer of linoleic acid has been
identified as the major diene conjugate in human plasma
and is thought to reflect free radical production. Using
high performance liquid chromatography this isomer was
also measured in serial blood samples taken from patients
in the first 48 hours of myocardial infarction. In
addition, to assessing the pattern of appearance of
neutrophil elastase and the diene conjugate of linoleic
acid following myocardial infarction, the effect of
thrombolytic therapy on these parameters was studied and
the results also compared with normal control subjects and
patients with stable ischaemic heart disease.
Using the three methods described, further information
about the pattern of events following myocardial
infarction was established both in patients treated with
and without thrombolysis.
The aim of this study was, therefore, to further elucidate
the role of the neutrophil in myocardial infarction and
study potential mechanisms of secondary myocardial injury.
This knowledge may be of therapeutic benefit as regulation
of the inflammatory response, for example, using non¬
steroidal anti-inflammatory drugs or free radical
scavengers may reduce secondary myocardial damage, thus
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providing another method for preserving myocardial




HISTORICAL BACKGROUND AND MANAGEMENT OF
ACUTE MYOCARDIAL INFARCTION
Fatal coronary atherosclerosis and thrombosis is now the
commonest cause of death in the Western World. Although
atheroma has been described in man for many centuries, the
clinical manifestations of coronary artery disease have
only become evident in the last three centuries. Angina
pectoris was first described by William Heberden in his
"Some account of a Disorder of the Breast" 1772 in which
he wrote "Those who are afflicted with it are seized while
they are walking, and more particularly when they walk
soon after eating, with a painful and most disagreeable
sensation in the heart which seems as if it would take
their life away, if it were to continue: the moment they
stand still, all this uneasiness vanishes".
Despite this excellent clinical description it was not
until 1799 that Parry expressed the concept of myocardial
ischaemia, relating abnormal coronary blood supply to
demand, and not until 1809 that Burns suggested that
cardiac pain was a consequence of ischaemia. It was then
a further century before Herrick clearly described the
association between coronary artery occlusion and
12
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myocardial infarction (Herrick, 1912). In a later
publication, Herrick recognised four groups of patients
with myocardial infarction; those in the first two groups
deteriorated rapidly and died soon after the onset of
symptoms. A third group in whom death was delayed for
hours, days or months with the possibility of recovery and
a fourth group who had mild symptoms and a better
prognosis which he related to obstruction of the smallest
branches of the coronary arteries (Herrick, 1918 and
1919). The electrocardiographic features of myocardial
infarction were then later described (Pardee, 1925) which
allowed physicians to distinguish between acute myocardial
infarction and angina pectoris in life.
With the ability to diagnose acute myocardial infarction
in life it became apparent that course and prognosis were
so variable that each case must be considered
individually. However, a number of poor prognostic
features were initially identified by White in a large
series from Massachusetts General Hospital (White, 1926).
He concluded that the following findings made the
prognosis worse: advanced age, a state of shock, an
abrupt and pronounced fall in blood pressure, the
prolongation of severe substernal pain for hours, the
duration of fever for more than a few days, the presence
of a high fever ( 103oF-104°F), a high leucocytosis,
especially if maintained for a week or more, rapid and
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marked cardiac dilatation/ gallop rhythm, ventricular
paroxysmal tachycardia, heart block, pulsus alternans,
cardiac asthma, congestive cardiac failure and embolic
phenomena. He also introduced the concept that
prognosis depended on the speed and degree of cardiac
involvement and that the duration and height of fever was
related to the size of the infarct. Thereafter numerous
studies were performed to establish which variables were
important in determining prognosis following acute
myocardial infarction, most incorporating the factors
described by White which he later discussed in a larger
series (White, 1932). Rosenbaum and Levine (1941) and
Billings et al (1949) found that the two most important
adverse prognostic features in terms of immediate outcome
and long term clinical status were the presence of shock
and cardiac failure, features which we now know are
related to the degree of myocardial damage. However,
Rosenbaum and Levine concluded that "weighing all the
information available together with the general appearance
of the patient enables the physician to make a fair
estimate as to the immediate prognosis". Thereafter, the
trend shifted from looking for a single isolated variable
to the development of a weighted score, based on the
severity of a number of adverse features. This led to
the development of the Coronary Prognostic Index (Peel,
1962; Norris, 1969) in an attempt to predict early
mortality. Though, numerous other studies have attempted
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to devise prognostic indices following myocardial
infarction the common factors in all studies appear
directly or indirectly related to the degree of myocardial
damage sustained. This concept was present in White's
original observations in 1926 when he suggested that the
prognosis depended on the speed and degree of myocardial
involvement following coronary thrombosis. It follows
that the greater the extent of myocardial infarction, the
poorer the residual cardiac function with the greater
likelihood of clinical evidence of cardiac failure or
shock, radiological changes of pulmonary oedema, abnormal
blood chemistry or leucocytosis. The concept that
residual myocardial function was the most important
prognostic feature of survival was confirmed by
Hammermeister in a study of 733 patients with documented
coronary artery disease (Hammermeister, 1979). Using
univariate and multivariate analysis of a number of
variables including clinical examination, resting
electrocardiogram, exercise testing, coronary
arteriography and quantitative left ventricular contrast
angiography he found that the variable most predictive of
survival was left ventricular ejection fraction.
Subsequent studies have shown that invasive (Verdouw,
1975) and non-invasive (Dewhurst, 1981) assessment of left
ventricular function is also of prognostic value in
predicting heart failure and sudden death following acute
myocardial infarction.
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While the pathological basis, clinical signs, diagnostic
investigations and prognostic indices of myocardial
infarction were established between the 1920's and 1950's,
little advance was made in therapy. Indeed the advice
given in the 1920's and 1950's varied little and was all
based on the relief of symptoms with particular emphasis
on diet, analgesia and strict bed rest. The lack of
emphasis on treatment in the intervening years was
emphasised by Biorck (1960) who wrote "There are few
diseases in the sphere of internal medicine where the
average mortality during four to six weeks hospitalisation
is over 30%, and if the patients with shock are
particularly considered, the figure is more than twice as
large. It is obvious that the task of treatment and
prevention is tremendous and it appears necessary that
more energy be directed to a considerable reduction in
these figures. The mere quantity of the problem may have
prevented us from calling all forces to arms in the
"infarct battle". However, our surgical colleagues would
never accept a mortality of this magnitude and would
certainly mobilise personnel and technique to bring such
figures down".
Shortly afterwards, following successful reports of
cardiopulmonary resuscitation techniques in acute
myocardial infarction (Julian, 1961) the first coronary
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care units were established in Australia and North
America. Early reports from such units were published in
1963 (Day, 1963; Brown, 1963) and emphasised the
importance of arrhythmias as the cause of death. This
knowledge led to a greater understanding of arrhythmias,
particularly those which are life threatening, with
subsequent improvement in the methods of treatment. An
Edinburgh study demonstrated that the coronary care units
reduced mortality to 16.4% in the first year of
operation compared to 23.4% in the preceding year and that
a significant proportion of patients survived treated
ventricular fibrillation (Julian, 1968). Despite these
benefits certain trials showed no difference in mortality
between home-management and hospital management groups
(Mather, 1976; Hill, 1978). These trials have been
subsequently criticised because they were of insufficient
power to assess effectiveness and examined low risk
groups, but they did serve to demonstrate that coronary
care units were of greatest benefit to high risk groups.
With the early successes in treatment of primary
tachyarrhythmias and conduction disorders, the main causes
of death became advanced left ventricular failure and
cardiogenic shock. It is now clear that to treat such
patients effectively invasive haemodynamic monitoring to
accurately monitor and adjust inotropic and vasodilator
drug therapy is required. However, to date, particularly
in cardiogenic shock, there is no evidence that final
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outcome is affected by these treatments and they are
costly in terms of time and resources.
Thus, it was apparent that the success of coronary care
units was largely due to treatment of arrhythmias but
patients were still dying from pump failure. As already
discussed the evidence suggests that residual ventricular
function is related to the extent of myocardial infarction
which in turn relates to prognosis. Thus, patients who
die from cardiogenic shock have massive infarcts (Page,
1971) whereas survivors of small infarcts tend not to
develop cardiac decompensation (Sobel, 1972).
It is on this background that attempts at early
intervention designed to limit infarct size have been
designed. The concept owes much to the early work of
Maroko and Braunwald (Maroko, 1971) who studied a number
of factors which might influence infarct size following
experimental coronary occlusion in dogs. They
demonstrated a number of factors which increased infarct
size, but also demonstrated a beneficial effect on infarct
size with propranolol. The early use of beta-blockade
following myocardial infarction in man has been shown to
reduce indirect indices of infarct size (Yusuf, 1985) and
long term beta-blockade reduces subsequent mortality and
reinfarction (The Miami Trial Research Group, 1985 and
ISIS-I, 1986). Many other forms of treatment
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aimed at reducing infarct size have been tried, including
nitrates, hyaluronidase, glucose-insulin-potassium, and
corticosteroids but the only other group of drugs which
have been shown to be of clinical benefit in man are the
thrombolytic agents.
The thrombolytic agent streptokinase was first used in
myocardial infarction by Fletcher in 1958, but despite
initial promising results did not enter routine clinical
use. The resurgence of the use of thrombolytic agents
follows the demonstration that coronary artery occlusion
leading to myocardial infarction is the result of thrombus
formation (De Wood, 1980), usually at the site of a
ruptured atheromatous plaque (Davies, 1985).
Studies have now shown that an intracoronary or
intravenous infusion of thrombolytic drugs will result in
lysis of the intracoronary thrombus with consequent
reperfusion, without unacceptable bleeding problems
(Schroder, 1983; Rentrop, 1985). All thrombolytic agents
act as plasminogen activators and exert their fibrinolytic
effect by converting plasminogen into its proteolytically
active form, plasmin. Plasmin then digests the insoluble
fibrin network into soluble fibrin degradation products
(fig la). Streptokinase and urokinase are currently
available for coronary thrombolysis, but two new agents

















Fig la Diagrammatic representation of the
fibrinolytic enzyme system, showing the
site of action of plasminogen activators.
also been shown to be effective in clinical trials.
These are tissue plasminogen activator which appears to
lyse thrombus rapidly with the additional advantage of
being non-antigenic (The TIMI Study Group, 1985) and
anisoylated plasminogen-streptokinase activator complex
(APSAC) which is effective given as a single intravenous
injection (Been, 1986). Assessing the efficacy of
thrombolytic therapy in terms of coronary artery patency
is difficult because of spontaneous reperfusion which
occurs in 20-30% of cases (De Wood, 1980). However, the
patency rate with intravenous streptokinase appears to be
in the range 55-75% (Neuhaus, 1981; Schroder, 1983)
compared to 60-80% with intracoronary streptokinase
(Khaja, 1983; Anderson, 1983). For practical purposes
the intravenous route of administration is the only
realistic option in view of the large numbers of patients
involved, the cost and the ability to administer therapy
outwith a cardiac catheterisation laboratory (Verstraete,
1985). Whilst coronary reperfusion is the immediate aim
of this form of therapy the object of thrombolysis is to
achieve functional myocardial salvage by reducing infarct
size. The Netherlands Interuniversity Study in 533
patients demonstrated that infarct size as measured by
release of cardiac associated enzyme was reduced in
these patients given streptokinase, and that this effect
was greater the earlier the treatment was started.
Enzyme release was reduced by 51% in patients treated
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within one hour, 31% in those treated between one and two
hours, but only by 13% in those treated between two and
four hours (Simoons, 1986). They also demonstrated
improved LVEF in the treated group (Serruys, 1986).
Similarly Been and co-workers demonstrated that the
earlier the treatment with anisoylated plasminogen-
streptokinase activator complex the more normal the LVEF,
again suggesting reduction of infarct size (Been, 1986).
Two large clinical trials have now reported reduced
mortality in patients treated with intravenous
streptokinase as one would expect if infarct size were
reduced. The Gruppo Italiano per lo Studies della
Streptochinasei nell Infarts Miocardico (GISSI) reported
their study of 11712 patients and have shown reduced
hospital mortality for streptokinase treated patients
which is maintained in the first year after infarction
(Gissi, 1986; 1987). Results from the Second
International Study of Infarct Survival, a trial aimed at
recruiting 20,000 patients have shown reduced in hospital
mortality in the streptokinase group (9%) compared to 12%
in placebo allocated groups (ISIS-2, 1987; 1988). It
would appear from these studies that the benefits are
greatest from patients treated early, particularly within
four hours and preferably within one hour.
Thus, there appears to be ever increasing evidence of the
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clinical effectiveness of early thrombolysis in reducing
infarct size and improving survival. Despite this
clinical evidence there is still considerable debate in
the literature about the possible deleterious effects of
reperfusion. Early animal studies on myocardial
reperfusion had predicted that potentially fatal
reperfusion arrhythmias may occur which might limit the
value of restoring an adequate blood supply particularly
if reperfusion is delayed (Smith, 1974). Clinical
experience has shown that although reperfusion arrhythmias
do occur they are not a serious adverse factor limiting
the use of thrombolytic drugs. Others have argued that
reperfusion of ischaemic myocardium can accentuate tissue
injury and have argued against widespread adoption of this
therapy, particularly if given late after the onset of
symptoms. Braunwald in discussing this problem spoke of
myocardial reperfusion being a double edged sword with the
advantages of reperfusion and reoxygenation being partly
offset by the extension of cellular damage that such
reperfusion may cause (Braunwald, 1985). One postulated
mechanism by which reperfusion injury may result is
through an exaggerated inflammatory response with release
of cytotoxic products from activated neutrophils with
consequent local tissue damage. Similarly, the
inflammatory response has also been implicated in
secondary myocardial injury following acute myocardial
infarction (Romson, 1982).
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The object of this thesis was to examine the role of the
inflammatory response, with particular emphasis on the
neutrophil, in myocardial infarction in man. Further, it
was hoped to assess the effect of thrombolytic drugs on
the acute inflammatory response and the potential for
reperfusion injury. In order to assess this it is
essential to understand the normal response to ischaemic
myocardial injury as well as the potential mechanisms of
reperfusion injury. These are outlined in chapter 2




THE INFLAMMATORY RESPONSE TO MYOCARDIAL INJURY
Inflammation is best defined as the local reaction of
vascular connective tissue to injury. The inflammatory
response can be divided into two types, acute and chronic.
In acute inflammation a succession of changes take place
within a short period which may be from minutes to days:
it is brought to an end either by a return of the tissue
to normal function with repair by fibrosis or progression
to chronic inflammation. It is important to realise that
chronic inflammation is not just acute inflammation
extended in time as the vascular and cellular changes are
markedly different. Most of the discussion hereafter
will relate to the changes seen in acute inflammation.
HISTORICAL BACKGROUND
For a long time inflammation was considered a well defined
and specific disease entity characterised by the four
cardinal signs, "color", "tumor", "rubor" and "dolor"
(heat, swelling, redness and pain). A fifth sign
"functio laesa" (loss of function) was wrongly attributed
to Galen in the second century, but the real source was
Virchow (Majno, 1975). It was later that John Hunter
noted that inflammation was a non-specific response
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(Hunter, 1794) and although this response follows a broad
general pattern it can vary in detail according to the
nature, site and severity of the injury. The advent of
the microscope allowed Conheim to study the nature of the
cellular response to injury which he described in his
lectures, published in English in 1889. These gave an
account of the morphological changes and demonstrated the
essential part of the vascular system and leucocytes in
the inflammatory response. In the same decade
Metchnikoff described phagocytosis and emphasised its
importance in the hosts defence to tissue injury
(Metchnikoff, 1883).
The local clinical signs of acute inflammation described
by Celsus and later Virchow are induced by (1) changes in
the microcirculation, (2) changes in vascular
permeability, and (3) the cellular exudate. These three
reactions may overlap and some share common mediator
mechanisms but for clarity these phases will be considered
separately.
Microcirculatory changes
Immediately following injury, there is a variable but
usually very short period of arteriolar vasoconstriction,
which is rapidly followed by arteriolar dilation and the
opening of new microvascular beds. In the immediate
vicinity of the injury, blood flow then begins to slow
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probably secondary to increased permeability of the
microvasculature, with escape of protein rich fluids into
the extravascular space. This results in increased blood
viscosity and stasis of red blood cells. In addition
there is greater adhesiveness and sticking of leucocytes
to the endothelial cells. On the periphery of the
injured area, however, blood flow remains increased.
Changes in vascular permeability
The permeability of the microvasculature is increased for
most of the duration of the inflammatory response. The
nature and degree of tissue injury determines the type and
duration of the permeability changes. With mild injury
the increase in permeability is immediate, but transient,
and is due to the contraction of the endothelial cells
lining venules. More severe injury, produces the same
initial response which is persistent, may last 24 hours
and also corresponds to contraction of venular endothelial
cells. With even more severe injury, such as thermal
injury, the increased permeability is result of
destruction of the capillary bed. In addition to the
increased permeability, the adhesiveness of the vascular
aspect of endothelial cells is also increased.
Cellular exudate
At the site of injury polymorphonuclear leucocytes adhere
momentarily to the endothelium and roll along the inner
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surface of the vessel wall, slower than the axial stream
of red blood cells, adhering briefly before they re-enter
the circulation. Later greater numbers of polymorphs
adhere to the endothelial surface with fewer being
dislodged, a process called margination. This process
is facilitated by the initial microcirculatory changes but
is a more complex interaction involving changes in cell
surface characteristics with mediators being derived from
both leucocytes and endothelial cells, particularly
products of arachidonic acid metabolism. Other mediators
including components of the complement system, are also
important in amplifying this response and are discussed
later. The marginated polymorphs, usually neutrophils,
then leave the intravascular space, initially by inserting
a pseudopodium between the endothelial cells followed
subsequently by the whole cell, a process called
diapedesis. Ultimately they emigrate into the area of
tissue damage and healing begins with phagocytosis of the
necrotic tissue which is facilitated by the release of
proteolytic enzymes from the activated neutrophils.
Repair ultimately occurs by fibrosis.
The phases of inflammation described above are part of an
elaborate homeostatic mechanism controlled by a number of
chemical mediators. An inflammatory mediator being an
endogenous substance whose levels increase at the site of
injury in association with the appearance of at least one
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tissue response or structural change. These mediators
can arise from plasma, from cells or from damaged tissue
and may affect more than one phase of the inflammatory
response. Many chemical mediators are now thought to be
important in inflammation and they have been broadly
divided into the following groups:
1. Vasoactive amines - histamine, 5-hydroxytryptamine,
platelet activating factor.
2. Plasma proteins:
a) Kinins - Hageman factor, kallikrein, bradykinin
b) Complement system (C3a, C5a)
c) Coagulation - fibrinolytic system - fibrinogen,
fibrin and fibrin degradation products.
3. Arachidonic acid metabolites:
a) Cycloxygenase pathway (prostaglandins,
thromboxane, endoperoxides)
b) Lipoxygenase pathway (leukotriene, HETE)
c) Chemotactic lipids
4. Lysosomal contents - cationic protein, elastase,
collagenase.




Although the mediators control and implement, the
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inflammatory response, it is now well established that at
least some part of the tissue damage observed in acute
inflammation is caused not by the inciting agent, but by
the inflammatory process itself. Secondary tissue
injury of this nature is probably brought about through
excess or uncontrolled production of mediators, many of
which may be derived from the neutrophil infiltrate
(Henson, 1972; Gallin, 1984). Some of these mechanisms
will be discussed more fully later in this chapter and may
be important in secondary myocardial injury.
The first detailed description of the histopathological
changes involved in the healing of myocardial infarction
in man was published by Mallory in 1939. This was a post
mortem series which predominantly examined the
histological changes in the first five weeks following
infarction. The description of events is very similar to
those later described in experimental acute myocardial
infarction in dogs (Sommers, 1964). Both studies
describe the acute and chronic inflammatory response to
myocardial injury with subsequent healing by fibrosis.
The histological changes following infarction develop
slowly with definite evidence of cell necrosis not being
detectable until 4 hours. In addition to the
morphological changes in the myocytes, the
microcirculatory changes and the appearance of the
cellular inflammatory infiltrate are also described.. At
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approximately 4 hours, dilatation of the blood vessels
with early neutrophil margination occurs at the periphery
of the infarct. By 24 hours the neutrophil infiltrate is
present spreading from the periphery to the more central
areas of infarction (figs 2a and 2b), is maximal by 3-4
days, and thereafter gradually diminishes before being
replaced by chronic inflammatory cells. Macrophages
begin to appear in the damaged areas around 4 days, at
approximately the same time as granulation tissue, and
begin to remove necrotic tissue. Between 6 and 10 days
lymphocytes and plasma cells are present with new collagen
evident at approximately 12 days.
NEUTROPHILS IN MYOCARDIAL INJURY
Though the inflammatory response is considered to be an
essential part of the normal host defence and healing
process following tissue injury, it is known that this
response can produce tissue damage per se. Indeed the
neutrophil has been implicated in the pathogenesis of a
number of disease conditions (Malech, 1987) and the same
oxidative and non-oxidative processes which are important
in killing microorganisms have also been implicated in
secondary tissue injury. The neutrophil may also have a
role in secondary myocardial injury following acute
myocardial infarction as well as contributing to
reperfusion injury. Interest in the role of the
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Figs 2a and 2b Low (fig 2a) and high power (fig 2b)
photomicrographs taken from an area of
myocardial infarction showing neutrophil
infiltrate within the ischaemic area of
myocardium.
neutrophil in myocardial injury stemmed from the initial
observations which showed rapid accumulation of
neutrophils in the area of myocardial infarction (Sommers,
1964), and a series of subsequent experiments have now
suggested a causal association between the neutrophil and
secondary myocardial injury. Romson and co-workers first
demonstrated that the cardioprotective effects of the non¬
steroidal anti-inflammatory agent ibuprofen on infarct
size were the result of reduced neutrophil infiltration in
the region of the infarct (Romson, 1982). Subsequent
work demonstrated that depletion of circulation
neutrophils prior to experimental coronary occlusion also
reduced infarct size (Romson, 1983). This work has
subsequently been confirmed, but it has been suggested
that the beneficial effects of neutrophil depletion are
less, the greater the duration of myocardial ischaemia
(Jolly, 1986). However, as the neutrophil obviously has
an essential role in wound healing it would not seem
desirable to totally block the local inflammatory response
to myocardial ischaemia and in certain animal species such
therapy may be associated with scar thinning (Jugdutt,
1985) and impaired ventricular function (Hammerman, 1983).
Activated neutrophils may produce tissue injury through
the release of a number of products (Henson, 1972) and can
themselves amplify the inflammatory response (Snyderman,
1981). The neutrophil can produce highly reactive and
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cytotoxic oxygen species including superoxide anion,
hydroxyl radical, hydrogen peroxide and singlet oxygen and
such reactive species can damage extracellular
macromolecules (Carrell, 1982), attack membrane
phospholipids (Meerson, 1982), and disrupt normal
mitochondrial function (Turrens, 1982) thus promoting cell
death or injury. Another mechanism by which neutrophils
may promote tissue damage is through the release of
lysosomal enzymes, into the microenvironment, capable of
proteolytic disruption of viable as well as irreversibly
injured tissue. One of the most potent of the lysosomal
enzymes is neutrophil elastase, a serine protease, whose
substrates include the following important matrix
molecules; elastin, collagen, proteoglycans, fibronectin
and fibrinogen. This enzyme is implicated in the
pathogenesis of a number of diseases, the best documented
of which is probably pulmonary emphysema (Janoff, 1985).
Numerous tissue and blood derived inflammatory mediators,
including complement, are involved in the initial
recruitment of neutrophils to the site of myocardial
injury (Maroko, 1978; Pinckard, 1975). However, in
addition, stimulated neutrophils may themselves amplify
this response by the release of arachidonic acid from
membrane phospholipid which is converted via the
lipoxygenase pathway to hydroxy-eicososatetranoic acids
and leukotrienes both of which are potent chemoatractants
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for neutrophils. The potential role of the neutrophil in
myocardial injury is shown diagrammatically in fig 2c, and
these mechanisms are similar to those postulated in the
pathogenesis of a number of other diseases (Malech, 1987).
The neutrophil may also contribute to reperfusion injury
following successful thrombolytic therapy. By definition
reperfusion injury refers to cell death or damage
resulting from restoration of the blood supply, in
contrast to the cell death or damage produced by the
preceding episode of ischaemia (Hearse, 1977). If
reperfusion is instituted at a time when ischaemic but
viable myocytes are present infarct size - is limited
(Reimer, 1979). Jennings first suggested that
reperfusion hastened the necrosis of some irreversibly
injured myocytes (Jennings, 1960) and several mechanisms
have now been proposed which may contribute to reperfusion
injury. These include (1) failure of the blood flow to
return uniformly to the ischaemic area, termed the no-
reflow phenomena which is probably due to the plugging of
the microvascular bed by neutrophils (Ames, 1968; Kloner,
1974), (2) the influx of calcium following reperfusion
leads to tissue disruption (Hearse, 1977), (3) oxygen
derived free radicals (McCord, 1985; Werns, 1986), and (4)
neutrophil release products (Braunwald, 1985). It can
therefore be seen that the neutrophil may have a key role
in reperfusion injury (fig 2d). The "no-reflow
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Diagram outlining some of the mechanisms of
neutrophil mediated myocardial injury
showing activation of the complement system




ISCHAEMIA AND REPERFUSION INJURY
-> ISCHAEMIA REPERFUSION
4 neutrophil influx
















Fig 2d Diagram showing a potential role for the
neutrophil and the acute inflammatory
response in reperfusion injury.
phenomenon probably represents an extension of the normal
cellular response to tissue injury and is now well
described in the heart (Kloner, 1974; Engler, 1986). A
substantial body of evidence now exists which indicates
that reactive oxygen species are involved in the
microvascular and parenchymal tissue injury associated
with reperfusion of ischaemic tissues (McCord, 1985). In
addition to the neutrophil other sources of free radical
production, following myocardial ischaemia, include the
conversion of xanthine dehydrogenase to xanthine oxidase,
mitochondrial production, the auto-oxidation of
catecholamines and the arachidonic acid cascade (Werns,
1986). Of these mechanisms, the xanthine dehydrogenase
pathway is well studied and may contribute to endothelial
cell damage but is unlikely to damage myocardium as this
enzyme is not present within myocytes (Manfredi, 1985).
Irrespective of the source of free radicals experimental
models have shown that free radical scavengers and agents
which prevent free radical production provide significant
myocardial protection in myocardial ischaemia followed by
subsequent reperfusion (Schlafer, 1982; Ambrosio, 1986).
The third mechanism by which neutrophils may produce
myocardial damage following reperfusion is by the release
of potent proteolytic enzymes. Neutrophil elastase is
known to be implicated in endothelial damage in vitro
(Smedley, 1986) but there has been little study of this in
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vivo and no study in relation to myocardial injury.
There is increasing experimental evidence which implicates
the neutrophil in secondary myocardial injury following
myocardial infarction and in reperfusion injury. There
has, however, been little work examining the role of the
acute inflammatory response in myocardial injury in man.
The object of this thesis was to study this question in
man, particularly as it may have therapeutic benefits if
neutrophil mediated secondary myocardial injury
contributes to secondary myocardial damage following
infarction.
Neutrophil behaviour following myocardial infarction was
studied in three ways; using radiolabelled autologous
neutrophils to image the neutrophil infiltrate at the site
of myocardial damage, by measuring plasma neutrophil
elastase as a marker of neutrophil activation and by
measuring the non-peroxide diene conjugate of linoleic
acid as a marker of free radical activity.
The methods for neutrophil separation and radiolabelling
are described in Chapter 3 as well as the subsequent in
vivo behaviour of the radiolabelled cells. The factors
influencing the uptake of Indium-Ill (^^In) labelled
neutrophils at the site of myocardial damage are discussed
in Chapter 4. In Chapter 5 a method for measuring
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infarct size (using Technetium-99ra pyrophosphate) and
evaluating the extent of ^In-labelled neutrophil
infiltrate is described,using single photon emission
computed tomography. The effect of treatment with and
without thrombolytic therapy on these parameters is also
studied.
In Chapter 6 the method for measuring plasma neutrophil
elastase, as a marker of neutrophil activation in normal
control subjects, patients with ischaemic heart disease
and acute myocardial infarction is described. The method
for measuring the non-peroxide diene conjugate of linoleic
acid, as a marker of free radical activity in the same
groups of subjects is described in Chapter 7. In acute
myocardial infarction the patterns of appearance of
elastase and the diene conjugate were followed in the
first 48 hours following the onset of symptoms and the
effect of treatment with thrombolytic agents on these
patterns also studied in Chapters 6 and 7. Chapter 8
summarises the findings and future avenues of research are
discussed in Chapter 9.
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CHAPTER 3
THE SEPARATION, RADIOLABELLING AND SUBSEQUENT IN-VIVO
BEHAVIOUR OF AUTOLOGOUS NEUTROPHILS
INTRODUCTION
The potential use of radiolabelled blood cell elements for
non-invasive diagnosis and improving the knowledge of in-
vivo cell behaviour has long been recognised. Initial
progress was thwarted, however, by the lack of a
radionuclide to label blood cells which was also suitable
for gamma camera imaging. In the last decade it has been
shown that leucocytes, and other cell elements, can be
labelled efficiently with Indium-Ill(mIn) chelated with
8-hydroxyquinolone (oxine) while retaining their in vitro
and in vivo functional activity (Thakur, 1977; Zakhireh,
1979). m-In-oxine is lipid soluble and diffuses
passively through the cell membrane thereby allowing
efficient incorporation of radioactivity into isolated
blood cells (Thakur, 1977b). The half life of 111In of
67 hours makes it suitable for cell kinetic studies as
well as determining subsequent localisation of the
radiolabelled cells without excessive radioactive decay,
while the two gamma photons (173 keV and 247 keV) permit
adequate gamma camera imaging.
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Ulln-labelled autologous neutrophils are often used
diagnostically to detect occult infection, but can also be
used to demonstrate active inflammation as in rheumatoid
arthritis (Uno, 1986), pancreatitis (Andersen, 1986) and
inflammatory bowel disease (Saverymuttu, 1982). In much
of the initial work mixed cell populations were labelled
but there has been increasing concern about the labelling
of radiosensitive cells, such as the lymphocytes, as
Ulln-oxine may induce severe chromosomal aberrations (ten
Berge, 1983). Further the use of mixed cell population
will result in labelling of cells not directly involved in
the inflammatory response, particularly erythrocytes,
which leads to poorer imaging with possible false positive
results because of blood pool activity. In addition,
mixed cell populations do not permit accurate assessment
of neutrophil responses and in-vivo behaviour in disease
states. For this reason the separation and
radiolabelling of pure neutrophil preparations is now
recommended (Thakur, 1981).
A number of techniques for the isolation and labelling of
pure neutrophils exist, but in general they are time
consuming and involve a number of steps including an
initial red cell sedimentation step with subsequent
preparation of discontinuous density gradients (Boyum,
1968). Percoll and Ficoll-Hypaque are two density
gradient media commonly used for the isolation of
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neutrophils. Percoll is based on colloidal silica coated
with polyvinylpyrolidone while Ficoll-Hypaque is a mixture
of a polysaccharide and a radiopaque contrast media. It
has been suggested that Percoll produces less in vitro
cell activation than Ficoll-Hypaque but this may have been
due to contamination of the Ficoll-Hypaque by bacterial
lipopolysaccharide (Haslett, 1985). There is also debate
about the best method of radiolabelling cells with ^in
(Danpure, 1982; Goedemans, 1982), but of the currently
used labels i^In-oxine is the most studied. Despite the
debate as to the best method, most workers agree whichever
method is used it is important that radiolabelled
neutrophils show normal in vivo kinetics in terms of
transit through lungs, and localisation in liver and
spleen (Saverymuttu, 1983). Non-viable cells show
greater lung retention with increased liver sequestration
(Thakur, 1977; Saverymuttu, 1983).
As the main purpose of this thesis was to examine the role
of the acute inflammatory response in myocardial
infarction, an acute medical emergency, a technique which
was rapid and simple to use was required to allow
neutrophil labelling soon after the patient's admission.
Mono-poly resolving medium (MPRM) is a commercially
available mixture of Ficoll-Hypaque which had been used to
isolate neutrophils for in vitro work from 5 ml of whole
blood in a single step (Ferrante, 1978). It had not been
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used for the preparation of autologous labelled
neutrophils for in vivo studies. Equally, 5 ml of blood
would provide insufficient neutrophil recovery for
subsequent labelling and imaging, therefore this technique
was evaluated as a method for isolating neutrophils in a
single step from 50 ml of whole blood. In addition to
measuring neutrophil recovery and efficiency of cell
labelling the transit of the radiolabelled neutrophils
through lung, liver and spleen was assessed after
intravenous bolus injection. Evidence of active
migration to sites of infection or inflammation was also




Investigations with ^In-labelled autologous neutrophils
were performed on 50 patients with suspected infection,
and various inflammatory conditions including acute
myocardial infarction (table 3 (i)). In 8 of these
subjects with no history of smoking or clinical or
radiological evidence of cardiopulmonary disease, the
pulmonary and blood pool clearance of 111In-labelled
neutrophils was assessed at the same time as accumulation
in liver and spleen.
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Cell separation
Venous blood was collected into a 60 ml syringe,
containing 300 units of preservative free heparin (Leo
Laboratories, Buckinghamshire, UK) via a 19G infusion set.
A full blood count and ESR were performed on 10 ml of
blood. All subsequent procedures were performed using
aseptic technique. In duplicate, 25 ml of blood was
layered over 12 ml Mono-poly Resolving Medium (Flow
Laboratories Ltd, Irvine, Ayrshire, UK) in a sterile tube
and centrifuged at 400G for 60 minutes. Differential
migration during centrifugation results in two cell bands,
one containing mononuclear cells and the other containing
polymorphonuclear cells, with a red cell pellet (fig 3a).
From the top plasma layer 8 ml was collected and
centrifuged at lOOOg for 10 minutes to provide platelet
poor plasma (PPP). The remaining plasma and the upper
cell band containing the mononuclear cells was discarded.
The neutrophils were then recovered from the lower cell
band, resuspended in 40 ml of phosphate buffered saline
(PBS, pH 7.4) and centrifuged at 400g for 10 minutes.
The supernatant was discarded and the cell pellet
resuspended in 10 ml of PBS. A 1 ml sample was taken to
determine total and differential white cell counts. Red
cell contamination was assessed in the 8 subjects in whom










Fig 3a Diagrammatic representation of the
separation of whole blood using Mono-poly
resolving medium (MPRM). After
centrifugation three distinct cell bands
are seen, the neutrophils can be harvested
from the middle band.
Labelling procedure
Ulln-oxine solution (20-49 MBq) (Amersham International
pic, Amersham, UK) was added dropwise to the remaining
suspension of neutrophils. After incubation at room
temperature for 15 minutes, 3 ml of PPP was added, then
the cell suspension centrifuged at 250g for 10 minutes.
The supernatant was transferred to a fresh tube to count
the amount of unlabelled ^^In. The cell pellet was then
resuspended to a volume of 5 ml with equal parts of PBS
and PPP. The activities of the cell suspension and
supernatant were then measured in a radioisotope
calibrator (ARC-120, Capintex Inc, New Jersey, USA) and
the labelling efficiency calculated. The cell suspension
was then drawn into a syringe ready for injection.
Cell counting
Cell counts were performed manually using a new improved
Neubauerchamber (0.100 mm). Blood films made from whole
blood and neutrophil suspension were stained with May-
Grunwald/Giemsa and a differential cell count determined.
The percentage cell recovery was calculated by comparing
the neutrophil count in whole blood with that in the
neutrophil suspension.
Gamma camera imaging and kinetic studies
Imaging was performed using a large field of view gamma
camera (GEC-400 AT, Maxicamera) with a medium energy
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collimator and energy windows set at 155-195 keV and 220-
285 keV. The gamma camera was linked to a PDP 11-34
computer (Digital Equipment Corporation).
Static planar images of the chest, abdomen and pelvis were
obtained in all subjects at 24 hours after injection.
Kinetic data were obtained in 8 subjects in the following
manner. The subject was positioned with the gamma camera
anteriorly over the chest and upper abdomen to allow
subsequent visualisation of lung, liver, heart and spleen.
A 19G venflon was then inserted into the right ante-
cubital fossa and attached to a 5% dextrose infusion.
The 5 ml of Ulln-labelled autologous neutrophils was then
injected as a bolus followed by a fast running 5% dextrose
infusion. A sequence of 64 x 64 matrix images was
acquired, from the moment of injection, over a 25 minute
time period with a varying time frame interval starting at
5 seconds and then increasing stepwise to 60 seconds for
the later images. The counts were then expressed as
counts per second to normalise for the varying frame
length.
To assess Ulln-neutrophil kinetics, the computer derived
planar images were inspected and regions of interest (ROI)
drawn manually around the heart, lungs, liver, spleen and
the whole field of view (fig 3b). The whole field plane
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Fig 3b Computer image approximately 15 minutes
after injection of ^In-labelled
neutrophils showing the regions of interest
drawn around lung, liver and spleen. Few
neutrophils remain within the pulmonary
circulation at this stage.
showing the maximum count-rate was assumed to represent
the total activity injected and was always in the first 1-
3 frames. The count rates from the other ROI's were then
expressed as a percentage of the maximum whole field count
rate and a time-activity curve created for each organ.
RESULTS
All results are expressed as mean ± SD.
Neutrophil recovery and labelling efficiency
Individual patient results are given in table 3(i). In 5
of the 50 patients studied, there was no clearly
detectable neutrophil band and therefore these were
excluded from further analysis. From the remaining 45
blood samples, the neutrophil recovery was 50.3 ± 17.8%
and only one sample contained the minimum recommended
number of cells for labelling of 1.5 x 107. All
neutrophil suspensions were labelled with Ulln-oxine with
a mean labelling efficiency of 70.8 ± 13.2%. In the 8
subjects in whom kinetic studies were performed red cell
contamination was 5.7 ± 2.6% and lymphocyte contamination
less than 0.5%.
Kinetic studies
The individual time activity curves for the 8 patients are
listed in table 3 (ii). The data for each organ are
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expressed as percentages of the maximum count rate
achieved in the whole field of view.
Heart count rates, which relate to circulatory blood pool
activity, for the group fell to 3% within 90 seconds and
after 5 minutes remained constant at 2% for the remainder
of the study. Lung count rates fell to 19% within the
first 90 seconds and thereafter fell slowly to 9% by 20
minutes. The liver counts rose rapidly to 16% by 15
minutes thereafter remaining constant, whereas the count
rate over the spleen continued to rise throughout the
study. The mean data for the 8 subjects is shown in
figure 3 (c).
Imaging results
Of the 45 patients in whom cell separation and labelling
was performed, all underwent planar imaging. In 18
patients positive images were obtained; 9 patients with
acute myocardial infarction, 4 localised abscess
collections, 2 patients with colitis, 1 patient with
pneumonia, 1 with Mycotic aneurysm, 1 with infected
venous access site. In none of the patients with
suspected occult infection, who had negative ^In-
autologous neutrophil scans, was this subsequently
detected. Examples of positive scans are given in
figures 3d and 3e.
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Time (min) after injection
Fig 3c Mean data showing the Ulln-labelled
neutrophil time courses for lungs, heart,
liver and spleen.
Fig 3d Anterior planar image in a patient with an
extensive left upper lobe pneumonia. Note
abnormal uptake of 11;1-In-neutrophils in the
left lung with normal uptake in liver and
spleen.
Fig 3e Posterior planar image in a patient with
ischaemic colitis of the descending colon,
note abnormal uptake of min-neutrophils
in colon from the splenic flexure to the
rectum with normal uptake in liver and.
spleen.
DISCUSSION
The results show that the described single step technique
with MPRM can be used to reliably separate neutrophils in
sufficient numbers for subsequent labelling. The method
has a number of advantages. Firstly, it avoids an
initial red cell sedimentation step with dextran,
hydroxyethyl starch or methylcellulose as is currently
normal practice (Danpure, 1982; Peters, 1983; Thakur,
1977a). Secondly, the method described does not require
the preparation of a discontinuous density gradient with
Percoll/saline of Percoll/plasma (Saverymuttu, 1983) and
is therefore technically less demanding. The third major
advantage is that the method is more rapid than those
previously described for "pure" neutrophil preparations
and involves less handling of the cells with the
concomitant risk of mechanical cell damage. Of the 50
attempted separations 5 were failures of which 3 patients
had documented chronic obstructive lung disease. We have
subsequently shown that this method is unreliable when
attempting to separate neutrophils from whole blood in
this group of patients and this may relate to
morphological or functional changes induced in red or
white cells by smoking. In the remaining patients in whom
clear neutrophil bands were seen, neutrophil recovery was
excellent and the cell yield more than sufficient for good
radiolabelling. Labelling efficiency is known to improve
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as neutrophil concentration increases, a factor which is
of importance if there is red cell contamination (Danpure,
1982). The extent of red cell contamination was small,
comparing favourably with previously published results
(Saverymuttu, 1983), and unlikely to interfere with the
radiolabelling of neutrophils with Ulln-oxine as
neutrophils are labelled more efficiently than red cells
(Danpure, 1982). Overall the labelling efficiency was good
at 70% and in agreement with previous studies (Thakur,
1977).
A number of studies have shown that poorly functioning or
damaged radiolabelled neutrophils will show prolonged lung
retention or greater liver sequestration (Thakur, 1977;
Weiblen, 1979; Saverymuttu, 1983). It was therefore
important to demonstrate that the cells separated with
MPR-M and subsequently labelled with ^^-In-oxine
demonstrated normal in-vivo kinetics. Our results are
consistent with functioning neutrophils with rapid
clearance from the pulmonary circulation, 80% of the
original activity clearing in 90 seconds and although the
magnitude of change is different, the l^In-time-activity
curves are similar for both heart and lung. The slight
difference in the two slopes is consistent with a degree
of lung retention, but this probably represents the normal
marginated pool of neutrophils in the pulmonary
circulation (Ambrus, 1954). Further, the difference in
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the curves at 25 minutes, lung counts being greater than
the heart counts, may also partly be explained by the
greater blood volume in the pulmonary vasculature compared
to heart. Splenic uptake continues to increase over the
study period compatible with pooling of the neutrophils in
the splanchnic vascular bed, whereas the count rates over
the liver plateau after approximately 15 minutes which is
against continued removal of damaged cells by the liver.
These data are consistent with previously described
neutrophil kinetic studies, and confirm normal in vivo
behaviour of the cells separated and radiolabelled by this
method.
neutrophils
Further, these radiolabelledAhave been shown to migrate to
sites of inflammation or infection which implies that they
are capable of responding to normal inflammatory stimuli.
The results also suggest that the acute inflammatory
response to acute myocardial infarction can be imaged by
this technique, but this was not invariable and the




IMAGING THE INFLAMMATORY RESPONSE TO ACUTE MYOCARDIAL
INFARCTION USING INDIUM-111 LABELLED
AUTOLOGOUS NEUTROPHILS
INTRODUCTION
With the development of large crystal scintillation
cameras (Anger, 1963) and improved radiopharmaceuticals,
radionuclide techniques for cardiac imaging have become
part of routine clinical practice. The imaging agents
which are commonly used are Technetium-99m (^9mTc)
labelled pyrophosphate for infarct avid imaging, 99mTc
labelled human serum albumin or red blood cells for blood
pool and radionuclide ventriculography, and Thallium 201
for studying regional alterations in myocardial perfusion.
A further recent advance in myocardial imaging has been
the introduction of single-photon emission computed
tomography (SPECT) (Holman, 1979). This has become
possible through new developments in computing combined
with the introduction of a rotating gamma camera which has
allowed three dimensional images to be reconstructed.
The major benefits of SPECT for cardiac imaging are
improved spatial separation of radioisotope uptake in
skeleton or chest wall from myocardium, plus the ability
to quantify individual tomograms allowing accurate
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measurement of infarct size or the area of ischaemia
(Jansen, 1985).
In addition to diagnostic imaging, radiolabelled blood
cells have also been used for myocardial imaging in
experimental models. Radiolabelled platelets have been
used to image acute coronary thrombosis and infective
endocarditis (Riba, 1979), while mixed leucocyte
preparations were first used to image the inflammatory
response to myocardial infarction in dogs. Further
studies using m-In-labelled autologous neutrophils showed
that anatomically distinct areas of increased myocardial
radioactivity uptake could be detected in all dogs studied
within 24-96 hours after infarction (Thakur, 1979). A
study in man evaluating the use of Ulln-labelled white
cell imaging, however, failed to detect any abnormal
activity in three patients following acute myocardial
infarction (McDougall, 1979). The feasibility of imaging
the inflammatory response to acute myocardial infarction
was better assessed in a later study which found that
positive uptake of labelled white cells could be seen in
over 50% of patients studied (Davies, 1981). The only
factor which appeared to influence the uptake of
radiolabelled neutrophils was the time from onset of chest
pain to reinjection of the cells; all patients injected
within 24 hours subsequently had positive images.
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The object of this part of the study was to determine
whether the method previously described in Chapter 3 to
separate and label autologous neutrophils allowed reliable
imaging of the acute myocardial infarction in man.
Factors which could potentially influence uptake of
neutrophils at the site of myocardial damage were also
studied including time from onset of symptoms to
injection, infarct size and concomitant drug therapy.
Single photon emission computed tomography was also
combined with conventional planar imaging to assess
whether this improved localisation and detection of
myocardial uptake of radiolabelled neutrophils.
PATIENTS AND METHODS
Patients
Thirty patients with acute myocardial infarction admitted
to the Coronary Care Unit were studied. All gave a
history of prolonged ischaemic chest pain, lasting longer
than 30 minutes, with electrocardiographic changes
associated with myocardial infarction and subsequently had
a rise in serum creatine kinase at least twice the upper
limit of normal. Infarct location was characterised
according to established electrocardiographic criteria as
anterior (including anteroseptal and anterolateral) or
inferior (including inferolateral and inferoposterior).
Patient details including time of reinjection of 111ln-
labelled neutrophils, activity administered and full drug
history are documented in table 4 (i).
METHODS
Preparation of H^In-labelled neutrophils
Autologous neutrophils were separated from 60 ml of whole
venous blood and labelled with 111In-oxine as described in
the methods section of Chapter 3.
Patient imaging
Within two and a half hours of the initial venesection,
all patients were reinjected with resuspended 11^In-
labelled autologous neutrophils (5 ml). Cardiac imaging
was performed the following day approximately 24 hours
after reinjection, therefore the earliest imaging time for
any patient was 36 hours after the onset of chest pain and
the latest 57 hours. The study protocol is shown in fig
4a.
All patients were imaged supine and standard planar images
acquired in the anterior, left anterior oblique and left
lateral position for 100,000 counts using a gamma camera
(GEC-400AT-Maxicamera). In 24 patients SPECT was
performed using the same gamma camera linked to a DEC













Study protocol. All times are related to
the onset of symptoms and patients were
imaged approximately 24 hours after
reinjection of the radiolabelled autologous
neutrophils.
minutes prior to the SPECT study, 40 MBq of 99hitc labelled
human serum albumin was administered to allow blood pool
imaging and hence myocardial localisation. A sequence of
64 simultaneous two dimensional images was acquired for
both m In and 99roijc as the head of the gamma camera
rotated through 360°, starting in the right anterior
oblique position (fig 4b). The total imaging time was 32
minutes and at the end of this period all 64 projections
are summed independently for both radionuclides, and
computer reconstructed to provide transverse, sagittal or
coronal images (fig 4c).
Image interpretation
The images for planar and SPECT imaging were assessed
separately. Planar imaging was graded positive when
Indium activity was clearly seen in the region of the
heart and negative where there was no detectable activity
or if the area of activity was inseparable from liver,
spleen or skeletal uptake. Dual isotope single photon
emission computed tomographic images were considered to be
positive when Indium activity was seen in all three
reconstructed views in relation to the 99m Tc blood pool
image.
Statistical analysis
Standard statistical methods were used to calculate means
and standard deviation. Results from the two different
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Fi-9 4b Single photon emission computed tomography
of the myocardium is performed with the
patient lying supine while the gamma camera
rotates through 360° starting from the
right anterior oblique position.
Computer reconstructed images showing
uptake in the transverse (T), sagittal (S),
coronal (C) planes in a patient with
anterior myocardial infarction using 111In-
labelled neutrophils .'3D' image also shown.
populations, those with positive and negative images, are
compared using Student's unpaired ' t' test or exact
probability test or unpaired Wilcoxon rank sum test as
appropriate. Values of p > 0.05 were not considered
significant.
RESULTS
Of the 30 patients with acute myocardial infarction, 23
had positive uptake of ^In-labelled neutrophils within
the myocardium using a combination of planar imaging and
SPECT. Three patterns of uptake were seen on planar
imaging: focal myocardial uptake (12 patients), diffuse
myocardial uptake (3 patients) and "doughnut pattern" (2
patients). Figure 4d shows an example of diffuse and
focal uptake and figure 4e a doughnut pattern of uptake.
In 6 patients where the planar images were considered to
be negative or equivocal, SPECT reconstruction showed
localised uptake within the myocardium an example is given
in fig 4f. In addition, the use of dual isotope SPECT
improved anatomical localisation of the infarct by
confirming its relation to cardiac blood pool imaged with
99mrrc_iabelled human serum albumin (fig 4g).
The details of the 23 patients with positive images and 7











Fig 4d Planar image in the left anterior obligue
view in a patient with acute myocardial
infarction using ^^In-labelled neutrophils
showing focal and diffuse uptake within the
myocardium; note normal uptake in liver and
spleen. The line drawing shows the areas
of uptake.
Planar image in the anterior view in a
patient with acute myocardial infarction
showing a "doughnut pattern" of uptake
within the myocardium of Ulln-labelled
neutrophils.
Planar image in the left lateral view in a
patient with myocardial infarction in whom
no definite uptake of radiolabelled
neutrophils can be seen (upper). The
corresponding SPECT reconstruction images
(lower) show definite myocardial uptake in
all three views (arrowed).
Simultaneous single photon emission
computed tomographic images in the
transverse plane. The 99mTc image shows
blood pool (left) in the left and right
ventricles while the ^In image (right)
shows extensive uptake within the
myocardium of both ventricles.
(i). The percentage of positive images increased as the
interval between onset of symptoms and injection of Ulln-
labelled neutrophils shortened; all patients injected
within 18 hours of infarction had positive images, whereas
only 4 out of 9 patients had positive images when injected
after 24 hours (fig 4h). Patients with positive images
were injected earlier after infarction (mean 20.3 + SD 6.4
hours) compared to those with negative images (27.6 ± 5.8
hours, p < 0.02). The other features documented in table
4 (i) age, sex, peak creatine kinase, peripheral white
blood cell count, administered dose of ^In and drug
therapy did not influence the imaging results.
DISCUSSION
The results confirm that Ulln-labelled autologous
neutrophils can be used to image the inflammatory response
to acute myocardial infarction. Two factors appear to be
important in determining whether uptake of radiolabelled
neutrophils can be detected within infarcted myocardium.
Firstly, in common with the previous study by Davies et al
(Davies, 1981), the time from onset of symptoms to
injection with radiolabelled neutrophils appears to be the
most important. In their study all patients injected
within 24 hours had positive images and similarly in this







Bar diagram showing that the percentage of
positive images decreases as the interval
between the onset of patient symptoms and
injection of lUln-labelled neutrophils
increases.
of symptoms had positive images. Overall the percentage
of positive images was greater in this study (77%)
compared to the earlier study (58%) and this in part
reflects the earlier mean time of reinjection at 20 hours
compared to 43 hours. These results suggest that the
stimuli for neutrophil activation and migration are
transient, a factor which may be of importance in further
studies designed to examine the role of the inflammatory
response in the pathophysiology of acute myocardial
infarction. Many potential inflammatory mediators may be
involved. Components of the complement cascade (C3a and
C5a) have been implicated as myocyte mitochondria activate
complement (Pinckard, 1975) and complement depletion of
animals reduces infarct size as well as the associated
inflammatory response (Maroko, 1978). Inhibition of 5-
lipoxygenase, the enzyme response for leucotriene B4
generation, a potent neutrophil chemo-attractant can also
reduce the degree of myocardial injury following
infarction (Fielder, 1984). Many other inflammatory
mediators may be important such as interleukin-1 and
platelet activating factor, but as yet no work exists on
their role in myocardial infarction. The observations
above combined with the evidence that neutrophil
depletion reduces infarct size in animal models (Romson,
1983) suggest that activated neutrophils may play a role
in extending myocardial injury following myocardial
infarction. Similarly, the neutrophil may be important
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in reperfusion injury following successful thrombolytic
therapy (Braunwald, 1985). If studies are to be designed
to further investigate the role of the neutrophil in
secondary myocardial injury in man then the imaging
results suggest that patients should be recruited within
the first few hours of the onset of symptoms. However,
they also suggest that it may be possible to influence
neutrophil migration for several hours after the onset of
symptoms and perhaps as long as 18 hours. Therefore,
drugs which influence neutrophil migration to the site of
myocardial damage, such as ibuprofen (Romson, 1982) could
be administered several hours after infarction while still
having a beneficial effect on myocardial salvage.
Thrombolytic therapy is the method most commonly used to
improve myocardial salvage and although this can be
administered 12-24 hours after infarction, the greatest
benefit is to patients treated within 4 hours and
preferably earlier (GISSI, 1986, 1987; ISIS 2, 1988).
Despite the clinical benefits of this therapy there is
still discussion about the potential harmful effects of
reperfusion, which may be in part mediated through
activation of neutrophils (Braunwald, 1985). 1;L1In-
labelled neutrophils may therefore provide a method to
study the inflammatory response in myocardial infarction
in patients treated conventionally or with thrombolytic
therapy providing patients were studied early in the
course of the infarct and definitely within 18 hours
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(Chapter 5).
While the time to injection of the radiolabelled cells in
relation to onset of symptoms is important and probably
reflects the presence of inflammatory mediators, the other
factor which improved the ability to detect myocardial
uptake of ^In-labelled neutrophils was the use of single
photon emission computed tomography in addition to
conventional planar imaging. This improved spatial
separation of areas of positive myocardial uptake from
uptake in adjacent bone, liver and spleen and with
simultaneous blood pool imaging with ^JJ^Tc-human serum
albumin allow confirmation of uptake in the region of
myocardium. Using this technique 6 patients had positive
myocardial uptake of 11!ln which could not be definitely
identified on the corresponding planar images.
Myocardial imaging with 1In-neutrophils is not a
technique for identifying myocardial infarcts, but single
photon emission computed tomography with 99mtpc_
pyrophosphate has been used to detect and quantify the
extent of myocardial infarction (Jansen, 1985). A
similar method is described in the following chapter to
assess the extent of uptake of Ulin-labelled neutrophils
in relation to infarct size.
None of the patient features such as age, sex, peak
creatine kinase, peripheral white blood cell count,
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administered dose of or concomitant drug therapy
appeared to influence the imaging results which supports
the suggestion that neutrophil migration is influenced by
the extent and duration of release of inflammatory
mediators.
This part of the study confirms that it is possible to
image the inflammatory response to acute myocardial
infarction in man and early injection of labelled cells
after the onset of symptoms is important if positive
uptake is to be seen. Providing patients are studied
early it should be possible to further examine the role of
inflammatory response in myocardial infarction and assess
the effect of therapeutic interventions such as
thrombolytic therapy. This problem is examined further
in the following chapter.
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CHAPTER 5
THE EFFECT OF TREATMENT WITH AND WITHOUT THROMBOLYTIC
THERAPY ON THE INFLAMMATORY RESPONSE AND INFARCT
SIZE, ASSESSED BY IMAGING TECHNIQUES, IN
PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Infarct avid myocardial imaging has emerged as a useful
non-invasive technique to aid in the detection,
localisation and quantification of myocardial infarction
(Turi, 1985). In infarct avid imaging a
radiopharmaceutical accumulates within a region of damaged
myocardium allowing its visualisation as a "hot spot".
The most commonly used agent is technetium 99-m stannous
pyrophosphate (99ntTc-PYP) first described by Bonte et al
in 1974. This radioisotope is normally used for bone
scans but is also taken up in damaged myocardium. Uptake
within damaged myocardium is dependent on residual blood
flow to the damaged area, with 99m«pc_pyp localising to
areas of irreversible cell damage associated with elevated
calcium levels, in whichever form the calcium is bound
(Buja, 1977). Uptake of the radiopharmaceutical within
the area of damage begins to increase after 4 hours but
scans in general become positive 12-24 hours after
infarction (Holman, 1978) and become increasingly abnormal
in the initial 24-72 hours, probably as collateral blood
flow develops. Successful reperfusion with thrombolytic
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therapy leads to early accumulation of 99itiTc-PYP within
myocardium and this may relate to the improved blood
supply to the area of damage (Wheelan, 1985).
*
Infarct avid myocardial imaging is used clinically to
diagnose myocardial infarction in patients when the
electrocardiogram is equivocal as in left bundle branch
block, previous infarction, suspected sub-endocardial
infarction or following cardioversion or during the
immediate post-operative period when enzyme results may be
misleading. However, imaging techniques can also be used
to assess infarct size which, because of the increasing
use of thrombolytic therapy to improve myocardial salvage,
is of current experimental and clinical interest. Using
planar imaging a crude grading system of myocardial uptake
of 99raijic_pyp (o to 4) has been devised (Parkey, 1974)
which in a large clinical series correlates well with
other non-invasive estimates of infarct size (Turi, 1985).
Animal models suggest that at least 3 grammes of
myocardial necrosis is required to be consistently
detected using 99m<pc_pyp ancj two-dimensional imaging
(Stokely, 1976). However, tomographic imaging systems
with three dimensional visualisation using single photon
emission computed tomography can detect smaller areas of
myocardial necrosis (Lewis, 1984). Using this technique
estimates of infarct size in man correlate well with
infarct size assessed by creatine kinase-MB isoenzymes
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(Jansen, 1985). The potential advantage of imaging
techniques over other methods is that they need only be
performed once whereas serum enzyme analysis requires
early and frequent sampling.
Another indirect estimate of infarct size may also be
obtained by measuring the left ventricular ejection
fraction by equilibrium radionuclide ventriculography
(Been, 1986) as it has been shown that ventricular damage
relates to the extent of myocardial damage (Hammermeister,
1979).
The results in Chapter 4 show that it is possible to image
the inflammatory response to acute myocardial infarction
using 111In-labelled autologous neutrophils. However, it
is necessary to inject the patients with the labelled
cells within 18 hours of the onset of symptoms to ensure
positive images. Previous studies have suggested that
the neutrophil may extend myocardial injury following
myocardial infarction (Romson, 1982; 1983) and may also
have a significant role in reperfusion injury (Braunwald,
1985). The role of the neutrophil in myocardial injury
in man has not been studied. The object of this part of
the study was to compare the degree of inflammatory
response with the extent of myocardial injury following
myocardial infarction in patients admitted to the coronary
care unit using imaging techniques. Radiolabelled
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autologous neutrophils were used to assess the
inflammatory response, and infarct size was assessed with
99impc_pYp# To iraprove detection and localisation of the
radioisotopes and allow quantification, the extent of the
inflammatory response and infarct size were measured using
single photon emission computed tomography (SPECT).
Further indirect estimates of infarct size were obtained
from serial measurement of plasma creatine kinase and by
assessment of the left ventricular ejection fraction prior
to discharge.
Finally, a comparison was also made between patients who
were treated conventionally following myocardial
infarction and patients treated with thrombolysis, in
particular to study the effects of thrombolysis on the




All patients were admitted to the coronary care unit with
a first acute anterior myocardial infarction. The
diagnosis of myocardial infarction was initially based on
the clinical history of ischaemic pain and
electrocardiographic evidence of anterior myocardial
infarction. The patients were individually assessed by
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the coronary care staff and deemed suitable or unsuitable
for thrombolytic therapy. Patients were considered
ineligible for thrombolytic therapy if admitted greater
than 4 hours after the onset of chest pain or who were at
risk from systemic anticoagulation, the remaining patients
were all given intravenous thrombolysis. All patients
gave informed consent for the study. Twenty one patients
had a 11 ^-In-labelled neutrophil scan followed
approximately 24 hours later by a 99mTc-pyrophosphate
scan. Of this group 10 patients were considered
unsuitable for thrombolytic therapy and were managed in
standard fashion. The other 11 patients were given
intravenous thrombolytic therapy within 4 hours of the
onset of symptoms and received either streptokinase
(Kabivitrum, Middlesex, UK) or anisoylated (human)
plasminogen-streptokinase activator complex (APSAC,
Beecham Pharmaceuticals, Epsom, UK). The 5 patients
given streptokinase were also given 100 mg hydrocortisone
and 10 mg chlorpheniramine prior to the 1 hour infusion of
1,200,000 units streptokinase in 100 ml 5% Dextrose.
APSAC was given to 6 patients in a dose of 30 units
administered as a single intravenous injection over 5
minutes.
Patients given thrombolytic therapy were subsequently
anticoagulated with intravenous heparin when the thrombin
time became less than 50 seconds and otherwise received
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standard care. In addition a further 5 patients who did
not receive thrombolytic therapy had a 99m<i>c-PYP scan at
48-72 hours and were used for the comparison of infarct
size assessed by creatine kinase. Patient details are
given in table 5(i) and 5(ii). Twenty patients had a
radionuclide ventriculogram to calculate left ventricular
ejection fraction prior to discharge.
Cell labelling
On admission to the coronary care unit the patients had a
19 gauge venflon inserted into a forearm vein for venous
access and within 16 hours of admission all patients had
60 ml of blood withdrawn into a syringe containing 300
units of preservative free heparin (Leo Laboratories,
Buckinghamshire, UK). 50 ml of blood was used to
separate and subsequently label neutrophils with 111In-
oxine as described in chapter 3. All patients were
injected with 5 ml of Ulln-labelled autologous
neutrophils within 18 hours of the onset of symptoms and
imaged the following day. 10 ml of blood was used to
measure full blood count and total creatine kinase.
Total creatine kinase was measured using a Beckman CK-NAC
reagent kit (Beckman Instruments, Carlsbad, USA) adapted
for use on a COBA's FARA centrifugal analyser (Roche
Diagnostics, Welwyn Garden City, England).
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^In-imaging
The patients were imaged approximately 24 hours after the
injection of 1 Uln-labelled autologous neutrophils, 10
patients having been treated conventionally and 11 treated
with thrombolytic therapy. Imaging was performed using
SPECT with the gamma camera (GEC-400AT, Maxicamera) linked
to a computer (Microdelta, Siemens). A sequence of 64
two dimensional images was acquired for 111In(energy
window 170-278 keV) as the head of the gamma camera
rotated through 360°, starting from the right anterior
oblique position. Total imaging time was 32 minutes
after which the computer summated and reconstructed the 64
projections to provide images in the transverse, saggital
or coronal plane.
99m«pc_pyrophosphate imaging
Pyrophosphate imaging was performed in the same patients
24 hours after ^In imaging for the 21 patients who had
both l^In and 99mTc-PYP, and between 48-72 hours post
infarction for the remaining 5 patients. All patients
had 500 MBq of 99mTC_pyp injected intravenously 2 hours
prior to imaging with SPECT. A sequence of 64 images was
acquired for "mTc(energy window 129-156 keV) as the head
of the gamma camera rotated through 360°. Total imaging
time was 12 minutes and summation and reconstruction
performed as for indium.
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Image interpretation and quantification
Both min and 99mipc images were graded positive when
uptake was visible in all three views (ie transverse,
saggital and coronal) in the region of the myocardium (fig
5a).
Quantification of the volume of uptake of Ulln and 99m>pc
was performed on a sequence of transverse slices showing
positive uptake for each isotope. Separate regions of
interest were drawn for the Ulln and 99mipc images (fig
5b). All transverse slices with positive uptake were
then analysed separately using a semi-automatic programme
to count the number of voxels (volume cell elements) with
uptake of ^In or 99mi>c greater than 65% of the peak
myocardial uptake (Jansen, 1985). An individual value
was then produced for the volume of myocardium with
neutrophil uptake and for the volume of infarcted
myocardium for a given patient. The ratio or ^^In
voxels/99m<rc voxels was used to assess the extent of the
inflammatory response in relation to infarct size.
Radionuclide ventriculography
Left ventricular ejection fraction (LVEF) was assessed by
gated equilibrium radionuclide ventriculography after the
injection of 750 MBq of "mTc-labelled human serum albumin
in 20 patients prior to discharge. After background
correction LVEF was calculated automatically, using a
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Fig 5a Computer reconstructed images of uptake in
the transverse (T) sagittal (S) and coronal
(C) planes in a patient with anterior
myocardial infarction using 99m<pc-
pyrophosphate.
Computer reconstructed image in the
transverse plane showing positive uptake of
99mTc-pyrophosphate within the left
ventricle and the region of interest used
to calculate the volume of infarct.
region of interest drawn around the left ventricle in end-
diastole. Thus
LVEF = end-diastolic counts - end-systolic counts
end-diastolic counts
STATISTICAL ANALYSIS
The data were not normally distributed and are expressed
as median and range. All statistics were performed by
non-parametric analysis using the Wilcoxon Rank sum test
for two independent samples (Mann-Whitney) or paired
samples as appropriate. Values of p < 0.05 were
considered significant and the data analysed by computer




a) Comparison of inflammatory response (111In) in
relation to infarct volume (99h»tc)
Assessed by ^In-labelled neutrophil imaging and "niipc_
PYP imaging respectively , the volume of the inflammatory
response (85 voxels, range 0-276) was significantly less
compared to the volume of infarct (190 voxels, 33-405, p <
0.0006) in the 21 patients who had both radioisotope scans
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peformed.
b) Comparison of treatment with and without thrombolytic
therapy on inflammatory response and infarct size
Patient examples showing the effect of conventional
therapy and thrombolytic therapy are shown in figure
5d. Ulln uptake was slightly larger in patients
treated without thrombolysis (114 voxels, range 19-276)
compared to patients treated with thrombolytic therapy (81
voxels, 0-160) but this difference was not significant.
There was no difference in infarct volume between patients
treated without thrombolysis (201 voxels, 77-405) and
those given thrombolysis (217 voxels, 111-323). However,
the ratio of ^In voxels/^^raTc-PYP was significantly
greater in patients treated without thrombolysis (0.79,
0.06 - 2.14) compared to patients treated with
thrombolytic therapy (0.41, 0 - 0.96, p < 0.05) (fig 5c).
There was no difference in peak creatine kinase between
patients treated conventionally (2508 units, 522-6255)
compared to those treated with thrombolytic therapy (2500
units, 533-6955). Though LVEF was poorer in patients
treated conventionally (36%, 15-51) compared to those
given thrombolysis (40%, 27-68), this was not significant.













Fig 5c Diagram showing the extent of uptake of
lUln- neutrophils within myocardium
expressed as a ratio of the size of
myocardial infarction measured by 99mTc
pyrophosphate in patients treated with and
without thrombolytic therapy. The ratio
is significantly less in patients treated
with thrombolysis (p < 0.05).
Fig 5d Single photon emission tomographic images
comparing the uptake of lUln-neutrophils
with "mTc-pyrophosphate. The upper pair of
images show easily detected uptake of ^^In
and 99mTc-pyp in a patient with anterior
myocardial infarction not given thrombolytic
therapy. The lower pair of images show
markedly reduced uptake of Ulln-neutrophils
(arrow) compared to 99it1Tc-PYP in a patient
with anterior myocardial infarction treated
with APSAC.
c) Correlation of imaging with Ulin and "mTc-PYP and
estimates of infarct size
There was no correlation between the l13-In uptake and the
three measures of infarct size; peak creatine kinase (r =
0.04), "^tc-PYP (r = -0.03) and LVEF (r = 0.34). There
was a correlation between 99mTC uptake and peak creatine
kinase (r = 0.53, p < 0.05), (fig 5e) and with LVEF (r = -
0.75, p < 0.001) (fig 5f). If the two patients with
extremely high values for peak creatine kinase (> 6,000
units), who differed from the remaining patients, are
excluded, a sub-group analysis shows an improved
correlation between 99mipc-PYP and peak creatine kinase (r
= 0.78, p < 0.001). The correlation between peak
creatine kinase and LVEF is shown in figure 5g.
DISCUSSION
The results confirm the previous observation that
inflammatory response to acute myocardial infarction can
be reliably imaged using li:LIn-labelled autologous
neutrophils. In only 2 patients could ^hn uptake not
be identified and both had received thrombolytic therapy.
Though these could represent clinical failures, it is
likely this is an effect of thrombolysis as the uptake of
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Fig 5e Figure showing the correlation between peak
creatine kinase and volume of infarct
measured by uptake of 99m"rc_pYP. Note the
two patients with high creatine kinase levels
in which 99m<rc_pYp appears to underestimate
infarct size.
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Fig 5f Figure showing the correlation between
infarct size assessed by "raTc-PYP and
residual left ventricular ejection fraction,
calculated by radionuclide ventriculography

























Fig 5g Figure showing the inverse correlation
between peak creatine kinase and residual
left ventricular ejection fraction,
calculated by radionuclide ventriculography
in patients with anterior myocardial
infarction.
For all patients, the inflammatory response assessed with
Ulln-labelled neutrophils, 24-48 hours after infarction,
was in general less extensive than the degree of
myocardial damage assessed by 99m<rc_pYp approximately 24
hours later. Interestingly, there was no correlation
between the extent of ^^In uptake and infarct size
assessed with 99m«pc_pYp creatine kinase or left
ventricular ejection fraction in this group of patients.
This confirms that imaging the inflammatory response to
myocardial infarction with radiolabelled neutrophils
should not be used to detect myocardial infarction. As
the neutrophil infiltrate does not correlate directly with
the degree of myocardial injury, this suggests other
factors influence the extent of the inflammatory response.
These may include the rapidity with which a collateral
blood supply develops or the rate of growth of new vessels
which can start as early as three to four days (Mallory,
1939). However, the results suggest the inflammatory
response to myocardial infarction, assessed by ^^In
uptake, is less in patients treated with thrombolytic
therapy, particularly in comparison to the infarct size
(fig 5c). Therefore, an alternative explanation which
could influence the acute inflammatory response may be the
rapidity with which spontaneous reperfusion of the
coronary vessel supplying the infarcted area occurs.
This hypothesis is compatible with the results of a
previous study which has shown that duration of
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myocardial ischaemia as well as neutrophil depletion
influences infarct size, (Jolly, 1986). In those
patients treated with thrombolytic agents it is possible
that the drugs themselves have a direct effect on
neutrophil activation or release of inflammatory mediators
but this has not yet been studied. It is interesting to
note that patients given hydrocortisone prior to
streptokinase do not appear to have a reduced inflammatory
response compared to patients treated with APSAC (fig 5c).
This suggests (although the numbers of patients studied
were small), the results in the thrombolytic group are not
merely influenced by the potential suppressive effect of
hydrocortisone on the inflammatory response and neutrophil
function (Hart, 1983). Similarly, lignocaine which can
also influence neutrophil function, (Goldstein, 1977) did
not affect the results.
Measuring infarct size using 99raTc-PYP is an accepted
technique (Turi, 1985), particularly when volume
measurements are made with single photon emission computed
tomography (Jansen, 1985). In this study, 99mTc-PYP
imaging was intended as an estimate of infarct size to
allow a comparison with the extent of the inflammatory
response measured similarly with Hl-In-neutrophils, and
was not initially designed to compare infarct size
determined by 99mTc-PYP and SPECT with other estimates of
infarct size. However, plasma creatine kinase, and
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residual left ventricular function were both measured in
this study and can be used to indirectly estimate infarct
size. As the blood samples for creatine kinase were
primarily obtained for diagnostic reasons, the sampling
was not frequent enough to allow estimation of total
creatine kinase (Sobel, 1972). Neither was
quantification of the cardiospecific MB fraction of
creatine kinase undertaken (Rodgers, 1977). All enzyme
methods of estimating infarct size are subject to
criticism as it has been shown that there is considerable
variability in the time course of enzyme evolution between
individual patients (Yusuf, 1981). In addition,
considerable doubts have been expressed regarding the
validity both of the use of peak creatine kinase (Sobel,
1972) and estimation of total creatine kinase release
(Roe, 1977), as an accurate reflection of infarct size,
since both methods involve a gross oversimplification of a
complex biological system. The problem . is compounded in
this study because following successful thrombolytic
therapy cardiac associated enzymes appear in the
circulation earlier (Shell, 1983), thus increasing the
variability of the time course of evolution of these
enzymes. Whether this early increased rate of enzyme
release following thrombolysis reflects a "washout of
enzymes" from reperfused myocardium (Schroder, 1983) or
reperfusion damage (Nayler, 1986) is a subject of debate.
Recent evidence would, however, suggest that the intensity
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of the enzyme release process even following myocardial
reperfusion is dependent on infarct size (Van der Learse,
1988). Despite these problems most authors would agree
that measurement of cardiac associated enzymes are a
useful if indirect estimate of infarct size.
The results from this study show a correlation between
infarct size assessed by 99niTc-PYP using single photon
emission computed tomography and peak creatine kinase,
though pyrophosphate may be less accurate in patients with
very high creatine kinase results. This correlation may
well have been better had more frequent samples been taken
for creatine kinase to allow more accurate assessment of
infarct size. Similarly, there was a good inverse
correlation between "mTc-PYP estimated infarct size and
residual left ventricular fraction in this group of
patients with first anterior myocardial infarction. Also
in agreement with previous studies, peak creatine kinase
inversely correlated with residual left ventricular
fraction (Hori, 1979; Dewhurst, 1981). Thus, the
combination of 99ititc-PYP and SPECT does appear to provide
a further indirect estimate of infarct size.
In summary, the results show that, following acute
myocardial infarction, the extent of the acute
inflammatory infiltrate and myocardial infarction can be
imaged using lUln-labelled neutrophils and 99m«rc_
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pyrophosphate respectively. In general the inflammatory
infiltrate appears less extensive than the degree of
myocardial damage, particularly in patients who have been
treated with intravenous thrombolytic agents, which
suggests that successful reperfusion is not associated
with an enhanced or prolonged acute inflammatory response.
The results are consistent with the neutrophil
contributing to secondary myocardial injury, but do not




PLASMA NEUTROPHIL ELASTASE AS A MARKER OF NEUTROPHIL
ACTIVATION FOLLOWING ACUTE MYOCARDIAL INFARCTION:
WITH A COMPARISON OF NO-THROMBOLYTIC
VERSUS THROMBOLYTIC THERAPY
The elastases constitute a group of proteolytic enzymes
produced by a variety of cell types including leucocytes,
monocytes, macrophages, platelets, smooth muscle cells,
skin fibroblasts and the pancreas. These enzymes differ
in their chemical structure, functional and immunological
properties, such that it is possible to identify each
independently (Janoff, 1985). Human neutrophil elastase
is synthesised primarily in the promyelocytes and stored
in the cytoplasmic azurophilic (primary) granules of
maturing neutrophils. It is a serine protease, with a
serine residue in position 195 of the enzymes primary
amino acid sequence, and a molecular weight of 33,000
daltons. It is antigenically and biochemically different
from other elastases with the possible exception of
monocyte elastase which is also a serine protease, though
this may merely represent neutrophil elastase which has
been bound and subsequently incorporated intracellularly
(McGowan, 1983). As monocytes at most contain 3% of the
elastase content of neutrophils, the neutrophil is by far
the greatest source of enzyme production and release.
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Only major stimuli, such as phagocytosis or cell death
will result in release of elastase from the primary
granules into the surrounding environment (Weissman,
1980), hence the use of this enzyme as a marker of
neutrophil activation.
Though the elastases secreted by other cells, such as
macrophages, smooth muscle cells and fibroblasts probably
have a role in the normal turnover of connective tissue
macromolecules, hydrolysis of matrix molecules by
neutrophil elastase probably reflects a pathological
process (Janoff, 1983), as this enzyme has a wide range of
substrates which not only includes elastin but also other
structurally important macromolecules such as collagen,
proteoglycans and fibronectin. Many other important
plasma proteins, such as immunoglobulin, fibrinogen and
complement, can also be hydrolysed by this enzyme
(Havemann, 1984).
Although it is evident that such large amounts of this
potent enzyme within a host defence cell have an important
physiological role (Weismann, 1983), excess or
uncontrolled release into the cellular microenvironment
has been implicated in the pathogenesis of a number of
diseases. Neutrophil elastase is considered to be of
importance in the development of certain pulmonary
diseases including emphysema, adult respiratory distress
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syndrome and cystic fibrosis (Janoff, 1985) but has also
been implicated in inflammatory bowel disease, rheumatoid
arthritis and glomerulonephritis (Malech, 1987).
Regulatory control of this potent proteolytic enzyme is by
the circulating inhibitory proteins alpha-1 protease
inhibitor and alpha-2 macroglobulin plus locally produced
low molecular weight regulators (Janoff, 1985). Alpha-1
protease inhibitor, previously called alpha-1 antitrypsin,
is the most important regulator of human neutrophil
elastase (Carrel, 1986). It is a glycoprotein with a
molecular weight of 52,000 daltons, synthesised in the
liver, which binds avidly to neutrophil elastase. Alpha-
1 protease has a methionine residue at position 358 in
the polypeptide chain which combines with the serine
hydroxyl group in the active site of neutrophil elastase
and thereafter forms an inactive complex. Despite the
presence of these inhibitors it is postulated that
neutrophil elastase may escape regulation in several ways.
Firstly, local enzyme release may overwhelm available
inhibitor; secondly, enzyme released in close proximity to
its substrates, may then compete locally with the
inhibitors for elastase and thirdly, the most important
escape mechanism may be the oxidation of the methionine
residue, at position 358 by oxygen free radicals, which
then renders alpha-1 protease incapable of inactivating
human neutrophil elastase (Johnson, 1979). As stimulated
neutrophils also release oxygen free radicals they can
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create a microenvironraent which is capable of oxidatively
inactivating alpha-1 protease (Carp, 1980), thus providing
an explanation for the secretion of elastase by the
neutrophil in the presence of its naturally occurring
inhibitor. The mechanisms of oxygen free radical
generation by neutrophils will be more fully discussed in
Chapter 7.
Neutrophil elastase has been implicated in the
pathogenesis of a number of disease conditions (Malech,
1987) and can be measured in a variety of body fluids
including blood. In vitro assays of functional
neutrophil elastase can be performed after separating
neutrophils or neutrophil granules and using synthetic
substrates (Bieth, 1974). However, this is not possible
in blood or other body fluids as neutrophil elastase will
be bound and inactivated by alpha-1 protease or alpha-2
macroglobulin. The technigues currently used to measure
elastase in blood are enzyme linked immunosorbent assay
(Senior, 1982) or a standard radioimmunoassay method
(Plow, 1982; Stockley, 1982), both employing antibody
raised against human neutrophil elastase. There has been
much work on human neutrophil elastase in inflammatory
conditions and pulmonary disease, but although it has been
implicated in myocardial injury (Weiss, 1977), this area
has been little studied. In vitro studies have shown
that neutrophil elastase can directly cause endothelial
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damage (Smedley, 1986) and it has been postulated that
elastase may contribute to the pathogenesis of
atherosclerosis (Robert, 1984). The experimental studies
which have implicated the neutrophil in secondary
myocardial injury following myocardial infarction and
myocardial reperfusion have already been discussed
(Romson, 1983; Jolly, 1986). One potential mechanism of
myocardial injury is through the uncontrolled release of
proteolytic enzymes including neutrophil elastase which
can be measuremed in blood and is used as a marker of
neutrophil activation (Plow, 1982; Abboud, 1986).
The aim of this study was to measure plasma neutrophil
elastase, using a sensitive radioimmunoassay technique, in
patients with documented ischaemic heart disease and
patients with acute myocardial infarction to assess the
extent of neutrophil activation compared to normal control
subjects. In addition, the pattern of appearance of the
enzyme in plasma following myocardial infarction was
assessed and a comparison made between patients treated
with and without thrombolytic therapy. The results were
also compared with plasma creatine kinase and the degree
of peripheral neutrophil leucocytosis.
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PATIENTS AND METHODS
Patients (Acute myocardial infarction)
Thirty two patients who had sustained their first acute
anterior myocardial infarction were studied, 21 of whom
had Hl-In-labelled neutrophil and 99raTc-PYP imaging.
The diagnosis was made as before on the history of
prolonged ischaemic chest pain and characteristic
electrocardiographic changes with a subsequent rise in
cardiac associated enzymes including total creatine
kinase. On admission 17 patients were considered
eligible for treatment with 1,200,000 units streptokinase
(pre-treated with hydrocortisone and chlorpheniramine) or
30 units aniisoylated plasminogen streptokinase complex
(APSAC). The other 15 patients were considered
ineligible for thrombolytic therapy because of late
admission (greater than 4 hours after the onset of
symptoms) or who were considered at risk from systemic
anticoagulation. These patients were treated in
conventional fashion, receiving standard drug therapy as
indicated. The details of the two patient groups are
summarised in table 6(i).
Protocol (acute myocardial infarction)
On admission to the coronary care unit a 19 gauge venflon
was inserted into a forearm vein, flushed with 2 ml 0.9%
saline and used for all subsequent blood sampling. Blood
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sampling was performed 6-8 hours after the onset of
symptoms and every 8 hours thereafter for the first 48
hours. The initial sample included a full blood count as
well as blood for total creatine kinase, and human
neutrophil elastase. Samples were also taken to measure
lipid oxidation products as a marker of free radical
activity and this will be discussed in chapter 7. All
samples were centrifuged immediately at 2000 rpm for 10
minutes at 4°C, the plasma separated and frozen at -20°C
until the assays were performed.
Patients also had a resting left ventricular ejection
fraction measured prior to discharge.
Patients and Protocol (controls and ischaemic heart
disease)
Blood was taken for full blood count and human neutrophil
elastase from 30 patients with a documented history of
ischaemic heart disease, based on coronary angiography
(12) or distant myocardial infarction and from 35 healthy
volunteers from laboratory and hospital staff. Details
of these groups are given in table 6(i). Again samples
for human neutrophil elastase were centrifuged immediately




Full blood count was measured automatically on a Sysmex E
5000 (TOA Electronics Limited, Kobe, Japan) and a
differential count obtained. Creatine kinase was
measured as described previously in chapter 5.
Human neutrophil elastase was measured in the Medical
Research Council/Scottish National Blood Transfusion
Service laboratory by Dr J Dawes. The assay used was a
standard radioimmunoassay using specific rabbit polyclonal
antiserum raised against human neutrophil elastase (Plow,
1982). The antigen having been purified from human
neutrophils following leukopheresis. The antibody is
specific for neutrophil elastase and does not cross react
with pancreatic or platelet elastases. The assay will
measure neutrophil elastase as the free enzyme or
complexed with its natural inhibitors alpha-1 antitrypsin
and alpha-2 macroglobulin. For the assay, 50 ul of
standard/sample was added to 50 ul 125i_eiastase plus 50
ul anti-elastase antibody (dilution 1:3000) and made up to
200 ul with buffer comprising 0.05 M phosphate (pH 7.4),
0.6 M NaCl and 2 mM EDTA, 130 mg/ml herparin, 20 units/ml
aprotonin and 2% heat inactivated serum. The samples
were then incubated overnight at room temperature and
separated with donkey anti-rabbit immunoglobulin
immobilised on Sepharose. After shaking for 45 minutes
at room temperature, the bound complex was separated from
83
free by sedimentation under gravity through 10% sucrose
solution, then aspirated and counted on a gamma counter
(NE 1600). The standard curve was constructed from 8
doubling dilutions of fresh frozen plasma and the
sensitivity of the assay was 0.5 ng/ml. Intraassay co¬
efficient of variation was less than 5%.
STATISTICS
The data were found not to be normally distributed as
tested by the Kolmogorov-Smirnov test. Results are
therefore expressed as median and range. Non-parametric
analysis was performed using the Wilcoxon rank sum test
for two independent variables (Mann-Whitney) values of p
< 0.05 were assumed to be significant and all data were
analysed by computer using the statistical package for
social sciences (SPSS Inc, Chicago, USA).
RESULTS
Comparison of control subjects with patients with
ischaemic heart disease and acute myocardial infarction
White cell count The white blood cell count was
significantly lower in the normal volunteers (median 5.8 x
10^/litre, range 3.4-9.3) than in patients with ischaemic
heart disease without recent infarction (6.7 x 10^/litre,
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5.2-12.6, p < 0.004) and both were lower than the initial
white cell count in patients with acute myocardial
infarction (16.4 x 109/litre, 7.9-33.7, p < 0.0001). The
neutrophil count was also lower in normal volunteers (3.6
x 109/litre, 1.8-6.2) compared to patients with ischaemic
heart disease (4.7 x 109/litre, 3.4-10.4, p < 0.004).
Both were lower than the initial neutrophil count in
patients with acute myocardial infarction (13.0 x
109/litre, 6.7-31.7, p < 0.0001) (fig 6a).
Plasma neutrophil elastase Compared to the normal
volunteers (18.6 ng/ml, 9.2-50.1) plasma neutrophil
elastase was significantly higher in the patients with
ischaemic heart disease (25.8 ng/ml, 12.2-49.5, p < 0.02).
The pattern of evolution of plasma neutrophil elastase was
different in patients treated conventionally or with
thrombolysis following acute myocardial infarction (see
below), therefore the results were analysed separately.
For both groups of patients with myocardial infarction the
plasma neutrophil elastase was significantly greater
between 8 and 48 hours compared to normal control
subj ects.
For patients treated conventionally, i.e no thrombolytic
therapy, the plasma neutrophil elastase was significantly







Total white cell and neutrophil counts in
peripheral blood in control subjects (C),
patients with ischaemic heart disease (IHD)
and initial count in patients with acute
myocardial infarction (MI).
compared to patients with ischaemic heart disease.
Patients treated with thrombolysis had significantly
higher levels of plasma neutrophil elastase between 8 and
40 hours, but not at 48 hours. The statistical results
are summarised in table 6 (ii and iii) and the individual
data shown in figures 6b and 6c.
Comparison of patients with myocardial infarction treated
with and without thrombolysis
Plasma neutrophil elastase The pattern of plasma
neutrophil elastase over 48 hours differed in the two
groups of patients with acute myocardial infarction and
this is shown diagrammatically in fig 6d. Patients given
intravenous thrombolysis had initial values (48.2 ng/ml,
25-250) which were significantly greater than patients
treated conventionally (32.6 ng/ml, 15.6-101; p < 0.025).
Those treated conventionally had, as a group, a later peak
at 40 hours (49.8 ng/ml, 21.4-196) which was significantly
greater than those treated with thrombolysis (34.2 ng/ml,
15.8-83; p < 0 . 037) .
Infarct size There was no significant difference in the
peak creatine kinase between patients treated
conventionally (1635 u/litre, 522-6255) compared to those
treated with thrombolysis (2059 u/litre, 533-6955). As a







































Fig 6b Individual results for plasma neutrophil
elastase between 8 and 48 hours in the
patients with acute myocardial infarction who
did not receive thrombolytic therapy. Mean
values for normal controls (N) and patients
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Fig 6c Individual results for plasma neutrophil
elastase between 8 and 48 hours in patients
with acute myocardial infarction who were
treated with intravenous streptokinase or
APSAC. Mean values for normal controls (N;
and patients with ischaemic heart disease
(IHD) are also shown.
f
Fig 6d Mean values (+ 1SD) for plasma neutrophil
elastase (PNE) in patients treated with (•)
and without (o) thrombolytic therapy
following acute myocardial infarction.
Levels of PNE are significantly different
between the thrombolytic and non-
thrombolytic group at 8 hours (p < 0.025)
and 40 hours (p < 0.037).
treated with thrombolysis (16 hours) compared to those
patients given thrombolysis (24 hours). Similarly there
was no significant difference in the left ventricular
ejection fraction measured by radionuclide
ventriculography, 10 days post-infarction, though patients
treated conventionally tended to have a lower LVEF (32%,
15-71) compared to those treated with thrombolysis (40%,
24-68) .
There was no correlation between white blood cell count or
neutrophil count with plasma neutrophil elastase in the
normal volunteers, patients with ischaemic heart disease
or the initial value for patients with acute myocardial
infarction.
There were weak correlations between creatine kinase and
plasma neutrophil elastase at 8 hours (r = 0.37, p <
0.036) 16 hours (r = 0.47, p < 0.011), 24 hours (r = 0.53,
p < 0.0028) and 40 hours (r = 0.39, p < 0.03).
DISCUSSION
White first recognised the association between the extent
of myocardial injury and degree or duration of
leucocytosis, which reflects the host inflammatory
response to tissue damage (White, 1926). More recent
studies have also shown an association between leucocyte
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count and ischaeraic heart disease. In a study of 464
patients who subsequently developed a first myocardial
infarction the leucocyte counts, measured on average 17
months earlier, were significantly greater compared with
two control groups, though this in part related to
cigarette smoking (Friedman, 1974). A more recent study
suggests that the risk of myocardial infarction is
approximately four times as great in persons with white
blood cell counts high in the normal range (greater than 9
x lO^/litre) compared to those with lower white blood cell
counts within the normal range (less than 6 x 10 9/litre)
and only 50-65% of this increased risk could be explained
by cigarette smoking (Ernst, 1987). This study, though
in a smaller group of patients with ischaemic heart
disease similarly shows that both the white blood cell
count and neutrophil count are increased compared to
normal non-smoking volunteers. In the patients with
acute myocardial infarction the early leucocytosis is part
of the normal response to stress, with catecholamine
release, resulting in neutrophils being mobilised from the
marginated pool within the pulmonary circulation (Bierman,
1952). However, stress does not explain the results in
the patients with ischaemic heart disease, as only 3
admitted to angina pectoris on the same day as blood was
taken and all denied current smoking, although
carboxyhaemoglobin was not measured to verify this. An
increased white cell count may be an important risk factor
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in myocardial infarction as neutrophils contribute
significantly to the rheological properties of blood,
particularly when activated as they become more adherent
to the endothelial wall, producing impaired blood flow
within the microcirculation (Kloner, 1974). Adherent
neutrophils may also contribute to endothelial damage by
the release of elastase (Smedley, 1986).
The results show that plasma neutrophil elastase is mildly
elevated in patients with stable ischaemic heart disease.
However, within the circulation, neutrophil elastase is
inactive, as it is complexed to the circulating inhibitors
alpha-1 protease and alpha-2 macroglobulin. These
inhibitors are present in much greater quantities in the
circulation, in gram quantities compared to nanogrammes of
elastase and, therefore, although the increase in plasma
neutrophil elastase reflects neutrophil activation does
not necessarily imply involvement in the pathogenesis of
disease. However, the inhibitory mechanisms may not
operate within the immediate microenvironment of the cell
(Janoff, 1985) and activated neutrophils are capable of
producing in vitro endothelial damage via elastase release
(Smedley, 1986). Thus, in patients with stable ischaemic
heart disease the elevated levels of neutrophil elastase
may reflect neutrophil activation in proximity to
endothelial cells with subsequent endothelial damage
(Robert, 1984) but equally may be a non-specific marker of
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pre-existing atheroma with possible mechanical damage to
the circulating neutrophil.
In patients with acute myocardial infarction, plasma
neutrophil elastase is significantly elevated for at least
the first 40-48 hours following the onset of symptoms.
This increase could be interpreted as an acute phase
response to stress as occurs with alpha-1 antiprotease and
other acute phase proteins (Laurell, 1975). However,
this is unlikely to explain the results for two reasons.
Firstly, the leucocytosis seen following myocardial
infarction, though part of the normal stress response,
does not correlate with plasma neutrophil elastase.
Secondly, the pattern of evolution of neutrophil elastase
differs between patients treated conventionally compared
to those given thrombolytic therapy, while both groups are
presumably exposed to similar degrees of stress following
myocardial infarction. This variation suggests that the
reasons for neutrophil activation may be different in the
two groups of patients.
In the patients treated without thrombolysis the
individual results suggest that although neutrophil
elastase is elevated, the values remain relatively
constant over the first 24 hours with later peaks at 32
and 40 hours. This coincides with neutrophil
infiltration into the area of damaged myocardium
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demonstrated by earlier histological studies (Mallory,
1939; Sommers, 1964), which can also be imaged within 48
hours of infarction using 1^^In-labelled autologous
neutrophils (Bell, 1987). The elevated plasma
neutrophil elastase may therefore reflect elastase,
complexed to alpha-1 antiprotease, which has been released
locally within the myocardium, by activated neutrophils,
and subsequently re-enters the circulation.
In contrast, those patients given intravenous thrombolytic
therapy, had higher values of plasma neutrophil elastase
initially which tended to fall thereafter. These results
agree with a recent publication (Gutteridge, 1988) and
suggests an alternative mechanism may account for the
early release of elastase, as few neutrophils will have
migrated into the area of myocardial injury by this stage.
Following thrombolysis elastase could be released from
neutrophils trapped within the coronary thrombus or from
neutrophils activated while adherent to the endothelium of
the reperfused coronary vessel (Kloner, 1974). The
previously discussed imaging results would support this
concept in that neutrophil infiltration appears less in
patients given thrombolysis (chapter 5) and as a group
they show little if any late rise in neutrophil elastase.
This suggests that the early increase in elastase
following thrombolytic therapy reflects intravascular
activation of neutrophils rather than neutrophil
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degranulation within the ischaemic myocardium.
Another explanation for the different pattern of
neutrophil elastase release in the two groups could have
been the additional drugs administered to the patients,
particularly lignocaine (Goldstein, 1977) and
hydrocortisone (Kart, 1984) which both reduce neutrophil
activation and lysosomal enzyme release in vitro. It
seems unlikely that lignocaine given for ventricular
tachycardia significantly affected the results as only 8
of 32 patients were treated in this manner, 3 treated
conventionally and 5 treated with thrombolysis. In
contrast half of the patients in the thrombolytic group
received streptokinase and hence were also given
hydrocortisone. A subgroup analysis of the patients
given thrombolysis did not show any difference in elastase
release between patients treated with streptokinase or
APSAC, and thus does not suggest that hydrocortisone
influenced the results. Again the imaging results
support this as patients given hydrocortisone prior to
streptokinase therapy did not have a greater reduction in
the uptake of ^^In-labelled autologous neutrophils
(chapter 5) when compared with patients treated with
APSAC. Previous studies examining the role of steroids
in myocardial infarction have used much larger doses of
methylprednisolone (Roberts, 1976; Kloner, 1978).
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The pattern of neutrophil elastase release was not
identical for individual patients in either the non-
thrombolytic or thrombolytic groups. Such differences
may be the result of spontaneous reperfusion in the non-
thrombolytic group and failed thrombolysis in the treated
group. It is known that the spontaneous reperfusion rate
following myocardial infarction is of the order of 20-30%
(De Wood, 1980). Therefore, of the group of 15 patients
treated conventionally one would expect 3-5 to show
spontaneous reperfusion, perhaps marked by an early
neutrophil elastase peak; such an early peak of elastase
was, in fact, seen in 2 patients. Similarly, we know
that intravenous thrombolytic therapy is successful in
achieving coronary reperfusion in approximately 60-70% of
cases (Laffel, 1984). If failed reperfusion is marked by
a late neutrophil elastase peak, as in patients treated
conventionally, we would expect a late peak in
approximately 5-7 patients treated with thrombolysis and
five patients demonstrate an obvious late peak.
Unfortunately, as patients did not undergo early
angiography it is not possible to confirm this hypothesis.
The results do, however, confirm that the white blood
cell, and particularly the neutrophil count is elevated in
patients with ischaemic heart disease. Not surprisingly
there is a leucocytosis following acute myocardial
infarction, but the white cell count also tended to be
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high, although within the normal range, in patients with
stable ischaemic heart disease. This does not determine
cause or effect, but it is interesting that, as well as
following myocardial infarction, in stable ischaemic heart
disease there is evidence of neutrophil activation as
measured by neutrophil elastase. The increase in plasma
neutrophil elastase persisted for the first 48 hours
following myocardial infarction. In patients treated
conventionally the increased elastase occurs when there
is known to be a significant neutrophil infiltrate within
the myocardium and may therefore be a mechanism of
secondary myocardial injury (Weiss, 1977). A late
increase in neutrophil elastase is not apparent in most
patients treated with thrombolysis who in general show an
earlier increase in plasma levels which may reflect
intravascular rather than extravascular elastase release
from activated neutrophils. The results therefore
suggest that neutrophil elastase may have a role in
delayed secondary myocardial injury in patients not given
thrombolytic therapy. In conjunction with the imaging
results which show successful thrombolytic therapy is not
associated with a greater neutrophil infiltrate at the
site of myocardial injury, the results suggest that




LIPID OXIDATION PRODUCTS AS A POTENTIAL MARKER OF OXYGEN
FREE RADICAL ACTIVITY FOLLOWING MYOCARDIAL INFARCTION:
WITH A COMPARISON OF NO-THROMBOLYTIC THERAPY
VERSUS THROMBOLYTIC THERAPY
A free radical is defined as an atom or molecule capable
of independent existence which has one or more unpaired
electrons, and as such is an unstable chemically reactive
species. Within this broad definition there are many
free radicals in chemistry and biology including the
oxygen molecule, a hydrogen atom and most of the
transition metal ions (Halliwell, 1985). Although oxygen
has two electrons it behaves like a bi-radical because it
has two unpaired electrons of parallel spin, therefore any
incoming pair of electrons attempting to react with oxygen
would need antiparallel spins and require one of the
electrons to undergo a spin inversion. To avoid this
"spin restriction", oxygen prefers to accept electrons one
at a time. Although this has major advantages in the
aerobic environment, as it slows down the reaction with
non-radicals, the disadvantage is that electrons when
added singly to oxygen lead to the formation of reactive
intermediates. When a single electron is added to the
ground state O2 molecule, the product is superoxide
radical O2-• Within biological systems further reduction
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of oxygen can occur with the addition of two and four
electrons in the presence of hydrogen, which results in
the formation of further reactive intermediates two of
which are free radicals (see below).
02 + e + H+ >H02—»H+ + 02~
02~ + e + 2H+ »H202
H202 + e > 0H~ + -OH
•OH + e + H+ *H20
Superoxide radical is produced in numerous biological
reactions, including the electron transport chain of
mitochondria and endoplasmic reticulum, where electrons
can "leak" into oxygen (Nohl, 1978), by activated
phagocytic cells following the respiratory burst (Babior,
1978 ) and in the presence of ischaemia following the
conversion of xanthine dehydrogenase to xanthine oxidase
(McCord, 1985). These mechanisms are outlined in fig 7
(a) . Once generated superoxide radical can assist the
formation of more damaging radical species by "Fenton
Chemistry" as shown in the equation below.
202_ + 2H+ ^H202 + 02
02" + Fe3+?=^ (Fe3 + -02>-»Fe2"t"-02-)?^ (Fe2+ + 02)
Fe2+ + H202 >Fe3+ + OH" + -OH














hypoxanthine _ • + h202+urate
mitochondrial electron transport
°2 +h2°2
Fig 7a Proposed sources of oxygen derived free
radicals and toxic oxygen metabolites in
myocardial ischaemia. 1) Neutrophil-
merabrane associated NADPH oxidase reduces
molecular oxygen initially to superoxide
anion (O2-) with production of hydroxyl
radical (OH ) and hydrogen peroxide (H2O2)
which is converted to hypochlorous acid by
myeloperoxidase. 2) Vascular endothelium:
with ischaemia xanthine dehydrogenase is
converted to an oxidase with accumulation
of hypoxanthine and production of O2-. 3)
Mitochondrial electron chain transport -
small amounts of oxygen free radicals are
normally produced but this increases in the
presence of ischaemia.
which is highly reactive and capable of damaging most
biological molecules. In addition to the inorganic
oxygen radicals, organic oxygen radicals can be produced
which are equally important biologically. Probably the
most studied organic oxygen radical reactions are the
autooxidation products of polyunsaturated fatty acids,
more commonly known as lipid peroxidation (Halliwell,
1985). Lipid peroxidation proceeds by a chain reaction
and polyunsaturated lipids are particularly sensitive to
free radical attack since they contain methylene groups in
interrupted double bond systems whose hydrogen atoms are
susceptible to abstraction. Such a reaction generates a
lipid conjugated diene which in the presence of oxygen can
react further to form hydroperoxides (fig 7b).
Alternatively the outcome is the formation of
malonaldehyde. Lipid hydroperoxides can be decomposed by
transition metal ions, such as iron to give alkoxy and
peroxy radicals which ultimately yield numerous carbonyl
compounds. This pathway may account for the stimulation
of lipid peroxidation following tissue damage, as metal
complexes may be released from vacuoles, organelles or
from other sequestered sites within the cell. It may
also explain the frequent observation that lipid
peroxidation accompanies many disease processes associated
with cellular injury. Lipid peroxides have themselves
been implicated in vascular endothelial damage (Blake,














Diagrammatic representation of the pathway
of lipid peroxidation for a polyunsaturated
fatty acid such as linoleic acid.
interpretation that cell damage can be caused by lipid
peroxidation has been questioned (Halliwell, 1984). In
addition, they may also regulate prostaglandin
biosynthesis (Lands, 1984).
Oxygen radicals are produced by numerous biological
reactions and are part of the normal physiological process
of cell metabolism in which oxygen plays a crucial role,
particularly in a number of highly organised enzyme
systems. However, free radicals if unimpeded will result
in denaturation of proteins, peroxidation of membrane
lipids and insterstitial matrix damage producing altered
enzyme activity and membrane permeability (McCord, 1985).
Fortunately, there are a number of endogenous antioxidant
mechansims found intracellularly and extracellularly which
directly or indirectly protect the host from free radical
mediated damage including enzymes such as superoxide
dismutase and vitamin C,table.7 (i).
Free radicals are inherently unstable and reactive
chemical species and characterstically therefore free
radical activity is extremely difficult to measure as they
rapidly react with and oxidise adjacent molecules
(Dormandy, 1984). Most methods, are therefore indirect
and measure free radical oxidation products, which include
the oxidation products of proteins measured by the
fluorescence/ultraviolet absorbance ratio of
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immunoglobulin G (Wickens, 1983) and the oxidative
products of lipids. Quantitative estimation of products
of lipid peroxidation include assays for conjugated
dienes, malondaldehyde, hydroperoxides and fluorochromic
products with features of Schiff bases (Buege, 1978).
These methods all have one disadvantage in that they are
measuring products of the normal pathway of lipid
peroxidation as well as products of lipid oxidation and
the thiobarbituric acid test which is often used is non¬
specific since compounds such as prostaglandins can
interfere with this assay (Halliwell, 1984). It is now
recognised when polyunsaturated lipids are exposed to free
radicals in the presence of protein they can form non-
peroxide diene-conjugated isomers. In humans 90% of the
diene conjugates in human serum or plasma consist of the
non-peroxide isomer of linoleic acid which can be measured
and used as a marker of free radical activity (Iversen,
1985; Fink, 1985).
Free radicals have been implicated in the pathogenesis of
many disease conditions including aging, inflammatory
diseases, cancer, adult respiratory distress syndrome and
tissue ischaemia and reperfusion (Dormandy, 1983; McCord,
1985). Their role in extending myocardial damage has
been studied in animal models of myocardial reperfusion,
largely by examining the protective effect of free radical
scavengers (Werns, 1986). More recent animal studies
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have attempted to measure free radicals in the ischaeraic
area of myocardium or from the venous effluent, but the
results are conflicting, some groups suggesting
increased free radical activity (Grill, 1987), while
others have been unable to confirm this finding (Rosamond,
1987). The different results may well be related to the
variety of experimental models used (Nayler, 1986).
Despite the increasing literature in experimental models,
little work has been done on free radical production in
man in ischaemic heart disease or following acute
myocardial infarction.
The aim of this study was to measure the non-peroxide
diene conjugated isomer of linoleic acid (PL-9, 11-LA') as
a marker of free radical activity in control subjects,
patients with stable ischaemic heart disease and following
acute myocardial infarction. In addition linoleic acid
(PL-9, 12-LA) was measured and the molar ratio of PL-9,
11-LA'/PL-9, 12-LA calculated to allow for any change
which may reflect the availability of the substrate,
linoleic acid. The appearance of this marker of free
radical activity was measured in plasma in the first 48
hours following myocardial infarction, by sequential blood
sampling, and the effect of non-thrombolytic therapy
compared with thrombolytic therapy. Results were





The patients and controls studied comprised the same
groups used for the measurement of plasma neutrophil
elastase in chapter 6. These consisted of 35 healthy
volunteers from the laboratory staff, 30 patients with
stable ischaemic heart disease and 32 patients with acute
myocardial infarction, 17 of whom were given intravenous
thrombolytic therapy. Details of the groups are given in
table 6(i) .
Protocols
The protocols were as described in chapter 6, blood also
being taken for the non-peroxide diene conjugate of
linoleic acid as a marker of free radical activity from
all groups, sequential samples being taken at 8, 16, 24,
32, 40 and 48 hours in patients with acute myocardial
infarction. Samples were centrifuged immediately and
frozen at -20°C until assayed.
METHODS




Plasma was obtained from heparinised blood samples and
stored at -20°C until assayed. PL-9, 11-LA and PL-9, 12-
LA were measured using high performance liguid
chromatography (Gilson, 302; Villiers-de-Bel, France) with
a variable wavelength ultraviolet detector set at 234 nm
or 205 nm (Gilson, H M, Villiers-le-Bel, France). A
Rheodyne injection valve (Corati, California, USA) was
used with a 50 ul sample loop. A Spherisorb ODS2 250 x 4
mm column containing 5 urn spherical particles (Hichrom,
Reading, Berks, UK) was used with a mobile phase of
acetonitrile/water/acetic acid 85:15:0.1 at a flow rate of
1.5 ral/min.
Plasma (0.5 ml) was mixed with 0.5 ml of a solution
containing 0.1 ramol/1 Tris pH 8.9, 1 mmol/1 methanol and
5000 u/1 phospholipase A2. This mixture was incubated at
25°C for 15 minutes after which 2 ml methanol containing
0.5% acetic acid and 50 mg/1 beta-eleostearic acid [18:3
(9, 11, 13)] was added to precipitate the protein and add
the internal standard. The preparation was centrifuged
and 2 ml supernatant applied to a "Bond-Elut" column which
had been washed twice with 2.5 ml propan-2-ol/acetonitrile
(2:1) and twice with 2.5 ml of a wash solution of
methanol/water/acetic acid (67:33:0.4). After the sample
had been applied to the "Bond-Elut" column it was washed
again with methanol/water/acetic acid and the sample
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eluted with 1 ml propan-2-ol/acetonitrile (2:1). The
eluate was directly injected into the HPLC using an auto-
sampler (Perkin-Elmer ISS-IOI, Buckinghamshire, UK). The
conjugated diene (PL-9, 11-LA') was measured at 234 mm and
the non-conjugated fatty acid linoleic acid (PL-9, 12-LA)
measured at 205 mm. The results are expressed as umol/1
and the intra-assay coefficient of variation for the
assays was less than 3.5%.
TRIS (Tris/hydroxymethyl) arainonethane and hydrochloride)
buffer and phospholipase A2 were supplied by Sigma,
Dorset, UK. All solvents were supplied by Rathburn
Chemicals Ltd, Lothian, UK.
Statistical analysis
This was performed as described in chapter 6. Results
are expressed as median and range.
RESULTS




There was no significant difference in PL-9, 11-LA'
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between normals (19.3 umol/1 7.5-32.9) and patients with
stable ischaemic heart disease (19.8 umol/1 7.9-43.2).
As a group the patients with myocardial infarction had
significantly higher levels of PL-9, 11-LA' at all sample
times 8-48 hours compared to controls, but only between 8
and 40 hrs compared to patients with ischaemic heart
disease. Statistical results are summarised in tables
7(ii and iii). The individual results for patients with
myocardial infarction are shown in figures 7c and 7d and
mean data in 7e.
PL-9, 12-LA
There was no significant difference in PL-9, 12-LA between
normals (390.5 umol/1, 281.0 - 634.4) and patients with
stable ischaemic heart disease (352.7 umol/1, 214.2
586.7) or either group compared to the patients with acute
myocardial infarction between 8 and 48 hours (406.4
umol/1, 240.8 - 584.6, 8 hour value).
Molar ratio PL-9, 11-LA'/PL-9, 12-LA
There was no significant difference in the molar ratio
between normals (4.7%, 1.9-9.1) and patients with
ischaemic heart disease (5.4%, 1.7-12.1). The molar
ratio in patients with acute myocardial infarction was
significantly elevated at sample times 8-48 hours compared
to controls, but only 8-24 hours compared to patients with

























Fig 7c Individual results for PL-9, 11-LA' between
and 48 hours in the 15 patients with acute
anterior myocardial infarction who were not
given thrombolytic therapy. Results for
control subjects (N) and patients with
ischaemic heart disease (IHD) are shown as
mean + 1SD for comparison.
80- THROMBOLYSIS
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Fig 7d Individual results for PL-9, 11-LA' between 8
and 48 hours in the 17 patients with acute
myocardial infarction treated with
thrombolytic therapy. Results for control
subjects (N) and patients with ischaemic
heart disease (IHD) are shown as mean + 1SD
for comparison.
0
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IHD 8 16 24 32 40 48
I
Time (hours)
Mean data (+ 1SD) for Pl-9, 11-LA' comparing
treatment with (•) and without thrombolytic
therapy (o). Levels are significantly
increased at all times compared to controls,
but there is no difference between treatment





o'—i—*—V—i > 1 ' 1 1
N IHD 8 16 24 32 40 48
Time (hours)
Fig 7f Mean data ( + 1SD) for the molar ratio of PL-
9, 11-LA'/PL-9, 12-LA comparing treatment
with (•) and without thrombolytic therapy
(o) .
Comparison of patients with myocardial infarction treated
with and without thrombolysis
PL-9, 11-LA', PL-9, 12-LA and the molar ratio PL-9, 11-
LA'/PL-9, 12-LA
The median values of PL-9, 11-LA' and the molar ratio were
highest in patients treated conventionally at 24 hours and
at 16 hours for these treated with thrombolysis, but there
was no significant difference between the two groups and
measured data is shown diagrammatically in figs 7e and 7f.
Similarly there was no difference in the substrate
linoleic acid (PL-9, 12-LA) between the two groups over
the 48 hours following myocardial infarction.
Correlations
There was no correlation between the peripheral white
blood cell count or neutrophil count and PL-9, 11-LA' in
the normal volunteers or the patients with acute
myocardial infarction given thrombolysis. Correlations
did exist for white blood cell count in patients with
ischaemic heart disease (r = 0.45, p < 0.02) and the non-
thrombolytic group of patients with myocardial infarction
(r = 0.63, p < 0.02), but this was not true for control
subjects or patients treated with thrombolysis. Further,
there was no correlation between molar ratio and white
blood cell count for any group. There was no correlation
with PL-9, 11-LA' or the molar ratio and creatine kinase
105
in patients with acute myocardial infarction.
DISCUSSION
Free radicals have been implicated in myocardial injury
following myocardial infarction, particularly following
reperfusion (Werns, 1986). Exposure of cell membranes to
oxygen radicals stimulates the process of "lipid
peroxidation", probably better called lipid oxidation.
The pathway of lipid peroxidation has been well studied
and is often used as a marker of free radical activity and
lipid peroxides have themselves been implicated in the
pathogenesis of ischaemic injury in myocardial infarction
(Meerson, 1982; Corr, 1984). The mechanisms proposed for
this include: a) changes in the lipid microenvironment of
membrane bound enzymes, receptors and ion channels which
can both activate and inhibit the functional activity of
such proteins; b) formation of new permeability channels
secondary to membrane fragmentation; c) formation of
cross-links between proteins and phospholipids of
biomembranes, coupled with irreversible inactivation of
the protein, and d) the oxidation of sulphydryl groups in
the active sites of membrane bound enzymes with resulting
loss of functional activity (Meerson, 1982). Whether
lipid peroxides are themselves cytotoxic is a subject of
debate, however, the products of this pathway are commonly
used as markers of free radical activity (Buege, 1978).
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Until recently most assays have measured products of lipid
oxidation and peroxidation. However, it is now
recognised that the main diene conjugate in human plasma
is the non-peroxide isomer of linoleic acid (PL-9, 11-LA')
which can be measured by HPLC and can be used as a marker
of free radical activity (Iversen, 1985).
The results show that plasma levels of PL-9, 11-LA' and
the molar ratio of PL-9, 11-LA'/PL-9, 12-LA, as markers of
free radical activity are not significantly increased in
patients with ischaemic heart disease compared to normal
control subjects. Further, as the patients with
ischaemic heart disease are older, this should accentuate
any age related effects, as ageing is thought to be
associated with greater free radical activity (Dormandy,
1983; Halliwell, 1985). However, the patients with
stable ischaemic heart disease are of similar age to those
with acute myocardial infarction allowing a comparison
between these groups. Patients with acute myocardial
infarction have increased levels of both PL-9, 11-LA' and
the molar ratio of PL-9, 11-LA'/PL-9, 12-LA in the first
32 hours after the onset of symptoms, compared with
control subjects and patients with ischaemic heart
disease.
In patients with acute myocardial infarction, the levels
of PL-9, 11-LA' and the molar ratio were both increased
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whether treated with or without thrombolytic therapy with
no statistical difference evident between the groups.
The molar ratio was slightly, but not significantly, lower
in the patients who received thrombolytic therapy. These
results suggest that reperfusion, following lysis of
coronary thrombus, is not associated with greater lipid
oxidation and hence by inference increased free radical
activity in the period 8-48 hours following myocardial
infarction. These results do not exclude a very early
and transient increase in free radical activity following
myocardial reperfusion suggested by some studies (Garlick,
1987), but do imply that reperfusion is not associated
with continued or delayed free radical activity in man.
Perhaps this reflects the beneficial effects of
reperfusing the heart with blood, rather than the cell
free perfusate often used in animal experiments, as free
radical damage may be reduced because of the presence of
catalase, the free radical scavenger, present in red blood
cells (Jolly, 1984; Agar, 1986). The results do not
necessarily conflict with the experimental evidence which
has shown that pre-treatment of animals with free radical
scavengers has a beneficial effect on myocardial salvage
which by inference suggests free radical mediated
myocardial injury (Ambrosio, 1986; Myers, 1985). Free
radical scavengers, such as superoxide dismutase, may also
exert their beneficial by effect by preventing the
generation of a superoxide dependent neutrophil
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chemotactic factor (McCord, 1982). Thus, by preventing
the accumulation of neutrophils at the potential site of
inflammation, not only will superoxide dismutase prevent
the tissue from direct attack by O2", but indirectly this
will prevent tissue injury by the additional mechanisms
available to activated neutrophils, such as the release of
potent proteolytic enzymes.
If neutrophils were the major source of oxygen free
radical activity, associated with secondary myocardial
injury, then one might expect a delayed increase in PL-9,
11-LA' coincident with neutrophil migration into the area
of myocardial injury. The late increase in neutrophil
elastase, seen in patients with myocardial infarction
treated without thrombolytic therapy, is consistent with
neutrophil degranulation within the area of myocardial
ischaemia, but a secondary increase in PL-9, 11-LA' was
not seen in either of the groups of patients with
myocardial infarction. Also, although a correlation
between the peripheral white cell count and PL-9, 11-LA'
was found in patients with stable ischaemic heart disease
and patients with myocardial infarction treated
conventionally, no correlation was found in normals or the
patients given thrombolysis. Further, the molar ratio,
which takes account of the available substrate, shows no
correlation with neutrophil count for any of the groups.
Therefore, the results do not show a consistent
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association between the degree of lipid oxidation and
neutrophils, therefore, the source or sources of
increased free radical generation in myocardial infarction
is still not fully established. As there is no
correlation between creatine kinase and PL-9, 11-LA' it
seems unlikely that PL-9, 11-LA' is merely a marker of
ischaemic cell injury (Halliwell, 1984) as it does not
appear to be influenced by infarct size.
In other species the diene conjugated non-peroxide isomer
of linoleic acid (9, 11-LA') may be generated from other
sources such as liver microsomes and can also reflect
dietary intake following bacterial dehydrogenation of
linoleic acid (Thompson, 1985). In this study, it is
unlikely that dietary sources could affect the results as
serial sampling over 48 hours showed that the levels of
PL-9, 11-LA' were initially high and fell with time,
whereas the levels of PL-9, 12-LA which may also be
affected by diet (Wood, 1987) did not alter significantly
with time. Further, changes in PL-9, 11-LA' which could
relate to the availability of the substrate PL-9, 12-LA
are incorporated by calculating the molar ratio which is
similarly increased following myocardial infarction and
follows a similar time course to appearance of PL-9, 11-
LA' .
The results suggest that there is increased free radical
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activity, as measured by products of lipid oxidation, in
patients following myocardial infarction but not in
patients with stable ischaemic heart disease. The
increase in free radical activity is greatest in the first
16 hours following myocardial infarction, but does not
merely reflect infarct size and shows no secondary or
delayed increase simultaneous with the acute inflammatory
infiltrate. Thrombolytic therapy is not associated with
greater delayed free radical production, compared to
treatment without thrombolysis, though this has been
postulated as a mechanism of reperfusion injury. The
source of increased free radical production following
myocardial infarction is therefore not yet established and
though the neutrophil may be involved, this is likely to




8.1 THE SEPARATION, RADIOLABELLING AND SUBSEQUENT IN-
VIVO BEHAVIOUR OF RADIOLABELLED AUTOLOGOUS
NEUTROPHILS
1. Mono-poly resolving medium, a Ficoll-hypaque based
cell separation medium, is a reliable method for
isolating neutrophils from whole blood. It is a
rapid method which allows separation of neutrophils
in a single step, thus reducing the handling of the
cells with the associated risk of mechanical damage.
Separation was not possible in patients with chronic
obstructive lung disease who represented most of the
10% failure rate.
2. The neutrophil recovery using this technique is good
and compares favourably with other methods for
separating neutrophils from blood. Lymphocyte
contamination is negligible and red cell
contamination is small and insufficient to interfere
with efficient radiolabelling of the neutrophils.
3. Autologous neutrophils separated using mono-poly
resolving medium can be radiolabelled efficiently
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with Indium-lll-oxine and when injected into
patients show normal in vivo behaviour. Thus,
after bolus injection of the labelled neutrophils
there is rapid clearance from the pulmonary
circulation, with no continued accumulation of
neutrophils within the liver to suggest removal of
damaged cells by the hepatic reticulo-endothelial
system. This is compatible with the cells
functioning normally within the circulation and as
the cells also successfully migrate to sites of
infection or inflammation this indicates that they
can respond to chemotactic stimuli.
8.2 IMAGING THE INFLAMMATORY RESPONSE TO ACUTE
MYOCARDIAL INFARCTION USING INDIUM-111 LABELLED
AUTOLOGOUS NEUTROPHILS
1. The acute inflammatory cellular infiltrate, within
infarcted myocardium, can be imaged in man using
Indium-Ill labelled autologous neutrophils.
2. The principal factor which determines whether
labelled neutrophils can be detected at the site of
myocardial infarction is the interval between the
onset of symptoms and injection of the labelled
neutrophils. Overall 77% of patients with acute
myocardial infarction in this study had positive
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Indium images. However, all patients injected
within 18 hours had positive images.
3. No other factor, including peripheral leucocytosis,
estimates of infarct size or drug therapy influenced
the likelihood of obtaining positive uptake of
labelled neutrophils in damaged myocardium.
4. Single photon emission computed tomography improved
the spatial separation of myocardial uptake of
labelled neutrophils from uptake in the adjacent
organs, namely spleen, liver and bone and hence
reduced the number of false negative results which
would have been obtained with conventional planar
imaging alone.
5. The combination of single photon emission computed
tomography with simultaneous radiolabelled
neutrophil and blood pool imaging increased the
certainty that uptake was present within the region
of myocardium and reduced the possibility of false
positive results.
6. The uptake of Indium-Ill labelled neutrophils at the
site of myocardial infarction is not a technique to
be used to confirm myocardial infarction.
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8.3 A COMPARISON OF THE INFLAMMATORY RESPONSE AND
INFARCT SIZE, ASSESSED BY IMAGING TECHNIQUES, IN
PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED
WITH AND WITHOUT THROMBOLYTIC THERAPY
1. The extent of Indiura-111 neutrophil uptake within
myocardium is significantly less compared to the
extent of myocardial damage assessed by Technetium-
99m pyrophosphate in patients with acute anterior
myocardial infarction.
2. There is no correlation between the inflammatory
response assessed by labelled neutrophils and the
size of myocardial infarction assessed by
pyrophosphate imaging, peak creatine kinase, or
residual left ventricular function.
3. Management of acute myocardial infarction, with
thrombolytic therapy, appears to reduce the extent
of neutrophil uptake relative to infarct size, when
compared with patients treated without thrombolytic
therapy.
4. Despite early injection of labelled neutrophils
myocardial uptake of Indium could not be detected in
two of the seventeen patients treated with
thrombolytic therapy. These may represent true
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failures, but equally may be the result of
successful reperfusion as thrombolysis appears to
reduce the extent of the acute inflammatory
infiltrate in acute myocardial infarction.
5. The estimation of infarct size by Technetium-99m
pyrophosphate correlates with the two other indirect
estimates of infarct size measured, namely peak
creatine kinase and residual left ventricular
ejection fraction.
8.4 PLASMA NEUTROPHIL ELASTASE IN ISCHAEMIC HEART
DISEASE AND PATIENTS WITH ACUTE MYOCARDIAL
INFARCTION TREATED WITH AND WITHOUT THROMBOLYTIC
THERAPY
1. As a group patients with stable ischaemic heart
disease have a slightly but significantly increased
level of plasma neutrophil elastase. As few
patients admitted to angina on the day of blood
sampling, ischaemic pain does not appear to
influence the levels of elastase. Whether the
elevated levels of plasma neutrophil elastase
reflect neutrophil activation in close proximity to
the endothelium with possible endothelial injury or
merely reflect neutrophil endothelial interaction at
sites of pre-existing ahteroma, remains to be
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established.
2. Plasma levels of neutrophil elastase are
significantly increased in the 48 hours following
acute myocardial infarction, compared with control
subjects or patients with ischaemic heart disease.
This increase does not correlate with the peripheral
neutrophil count at the time of sampling.
3. The patterns of appearance of neutrophil elastase in
plasma differs in patients treated without
thrombolytic therapy compared to patients who were
given thrombolytic agents. Patients managed
conventionally showed only a moderate increase in
neutrophil elastase over the first 24 hours, but had
a late peak at 40 hours. This increase occurs when
neutrophils are present within the injured area of
myocardium and may reflect local myocardial release
with the potential for secondary myocardial injury.
In contrast, patients given thrombolytic therapy had
high initial values of neutrophil elastase at 8
hours which tended to fall over the next 48 hours.
It is unlikely that many neutrophils will have
migrated into the damaged area of myocardium as
early as 8 hours, therefore elevated levels at this
stage may reflect intravascular neutrophil
activation following contact with damaged
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endothelium or release from neutrophils trapped
within the thrombus.
4. None of the patients in this study underwent
emergency coronary angiography therefore the true
rates of spontaneous reperfusion or unsuccessful
thrombolysis are not known which makes
interpretation of the different pattern of results
in patients treated with and without thrombolysis
difficult.
5. A correlation exists between plasma neutrophil
elastase and creatine kinase which suggests that the
release of neutrophil elastase is in some way
related to the extent of myocardial injury and may
therefore be a mechanism of secondary myocardial
injury.
8.5 LIPID OXIDATION PRODUCTS AS A MARKER OF FREE RADICAL
ACTIVITY IN PATIENTS WITH STABLE ISCHAEMIC HEART
DISEASE AND ACUTE MYOCARDIAL INFARCTION TREATED WITH
AND WITHOUT THROMBOLYTIC THERAPY
1. There is no difference in the plasma levels of the
non-peroxide diene conjugated isomer of linoleic
(PL-9,11-LA') acid or the molar ratio of this isomer
with the substrate linoleic acid in patients with
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stable ischaeraic heart disease compared to control
subjects. This suggests that there is no
significant increase in lipid oxidation and hence
free radical production in patients with stable
ischaemic heart disease.
2. In patients with acute myocardial infarction free
radical activity assessed by this method was
significantly greater than patients with stable
ischaemic heart disease or control subjects. The
levels were higher in the first 24 hours and fell
towards normal values in the period 24 - 48 hours
following the onset of symptoms.
3. The levels of linoleic acid were no different in
control subjects, patients with ischaemic heart
disease or acute myocardial infarction. It is
therefore unlikely that dietary intake of
unsaturated fatty acids has influenced the results.
4. Although the levels were increased following acute
myocardial infarction, there was no difference in
the non-peroxide diene conjugate of linoleic acid or
the molar ratio in patients treated with or without
thrombolytic therapy. The molar ratio was
slightly, but not signficantly, less in patients
treated by thrombolysis compared to patients treated
119
conventionally. These results do not suggest that
successful reperfusion is associated with greater
free radical production, though this is a postulated
mechanism of reperfusion injury, following
successful thrombolysis.
5. It has been suggested that increased lipid oxidation
products merely reflect the extent of tissue injury
(Halliwell, 1984). However, the levels of the non-
peroxide diene conjugate of linoleic acid or the
molar ratio do not correlate with infarct size
assessed by creatine kinase in this study. This
suggests that PL-9,11-LA' does not purely reflect
cell membrane damage and is consistent with
increased free radical activity.
6. The source of free radical production, assessed by
lipid oxidation, is not established. The
correlation of PL-9,11-LA' with neutrophil count was
not consistent and furthermore was not found with
the molar ratio in either patients with stable
ischaemic heart disease or acute myocardial
infarction. Also as there was no late increase in
plasma PL-9,11-LA' coincident with neutrophil
infiltration of damaged myocardium, this would





GENERAL DISCUSSION AND FUTURE DIRECTIONS
The purpose of this thesis was to examine the potential
role of the acute inflammatory response, with a particular
emphasis on the importance of the neutrophil, in secondary
myocardial injury following myocardial infarction and to
also study the effects of thrombolytic therapy on this
response. This was undertaken in three ways; (1) by
imaging the neutrophil uptake at the site of myocardial
damage using radiolabelled autologous neutrophils, (2)
seguential measurements of plasma neutrophil elastase as a
measure of neutrophil activation, and (3) sequential
measurements of the non-peroxide diene conjugate of
linoleic acid in plasma as a marker of free radical
activity.
The method described for the separation and radiolabelling
of autologous neutrophils from whole blood in a single
step proved to be rapid and efficient in patients with
acute myocardial infarction. These neutrophils
demonstrated normal in vivo behaviour with rapid pulmonary
clearance and migration to sites of infection and
inflammation suggesting that they were functionally
active. Providing patients with myocardial infarction
were injected with the radiolabelled cells within 18 hours
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of the onset of symptoms the uptake of neutrophils at the
site of myocardial damage could be reliably imaged. This
suggests that the main chemotactic stimuli for neutrophil
migration occur early and probably do not persist for
greater than 24 hours. Complement components in
particular C3a and C5a are known to be important in
neutrophil migration to the area of myocardial damage
(Pinckard, 1975; Hartmann, 1977). The advent of
monoclonal antibody based assays to these components
should make it possible to determine the extent and
duration of complement activation following myocardial
infarction. Many other inflammatory mediators may be
involved, particularly the leukotrienes, interleukin and
platelet activating factor and again the introduction of
reliable assay methods should allow improved understanding
of the mechanisms controlling the inflammatory response to
myocardial injury.
Single photon emission computed tomography (SPECT) is a
significant advance in myocardial imaging: SPECT allows
spatial separation of myocardial uptake 11]-In-neutrophils
and 99mTc-pyrophosphate of from uptake in surrounding
organs including bone. It also allows quantification of
radionuclide uptake by counting the number of voxels
(volume cell elements) with uptake of Ulln or 99mTc
present within the region of myocardium. In general,
using this method, the inflammatory infiltrate assessed by
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llljn-neutrophil imaging was less extensive than the
actual size of infarct assessed by pyrophosphate imaging.
Further, the patients who were treated with thrombolytic
therapy appeared to have a less marked neutrophil
infiltrate for a given infarct size compared to patients
who did not receive thrombolytic therapy. Previous
observations suggested that successful reperfusion was
associated with an early and increased neutrophil
infiltrate (Sommers, 1964). However, these studies may be
describing an early and transient component of the normal
vascular phase of the inflammatory response to tissue
injury. As successful reperfusion of an occluded vessel
will produce earlier neutrophil influx and margination
with some neutrophil extravascular migration but does not
necessarily imply the inflammatory response is amplified,
which is the common interpretation. It was not possible
to address the question of the progression of the
neutrophil infiltration in this study because of the
difficulty in moving patients to a gamma camera in the
early hours of their infarct. Although accurate
quantification of the inflammatory infiltrate could not be
studied, it should be possible to assess the course of
this response using a mobile gamma camera with sequential
imaging of the patients in the coronary care unit,
providing patients could be injected with autologous
neutrophils in the first few hours of their acute infarct.
A comparison could then be made between patients treated
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with and without thrombolytic therapy on the rate and
extent of development of uptake of autologous neutrophils
at the site of myocardial damage.
This study did not show a significant reduction in infarct
size, estimated by peak creatine kinase, myocardial uptake
o f ^mTc-pyrophosphate or residual left ventricular
function, in patients treated with thrombolytic therapy
compared to those treated without thrombolytic therapy.
This almost certainly reflects the size of the study group
as we know from large multicentre trials that thrombolysis
does improve mortality (Gissi, 1987; ISIS-2, 1988) and
preserve myocardial function (Serruys, 1986). Despite
similar infarct sizes, the neutrophil uptake was less in
patients treated with thrombolytic agents, suggesting that
some of the beneficial effects of thrombolysis may relate
to reduction of the inflammatory response and associated
secondary myocardial injury. If this is the case it
probably would not be beneficial and perhaps even harmful
to further reduce the inflammatory response in these
patients because of the essential part the inflammatory
process plays in normal healing. However, downregulation
of the inflammatory response may be a mechanism for
improving myocardial salvage in patients not eligible for
thrombolytic therapy.
Corticosteroids are known to suppress inflammation, and
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two studies in which an early but large doses of
corticosteroids have been given suggest this can reduce
infarct size (Morrison, 1976; Hammerman, 1983) but these
results have been overshadowed by the potential
deleterious effects on scar healing shown with the use of
higher multidose therapy (Roberts, 1976; Kloner, 1978).
The effects on scar thinning with the risk of ventricular
aneurysm and rupture probably reflects the catabolic
effects of steroids on collagen metabolism, rather than
the anti-inflammatory effects, hence the potential benefit
of a single early dose of corticosteroid following
myocardial infarction. Although it would not be ethical
to compare prolonged steroid therapy with early single
dose steroid therapy it would, on the available evidence,
be possible to compare early administration of high dose
corticosteroids with no corticosteroid on infarct size,
neutrophil uptake and residual ventricular function
following acute myocardial infarction using the methods
described in this thesis.
To further determine whether the neutrophil is an
important factor in secondary myocardial injury drugs
which have a more specific effect on neutrophil function
could be used as experimental tools; for example some of
the non-steroidal anti-inflammatory agents. Ibuprofen
has been shown to reduce the infarct size in animals
(Romson, 1982) and other workers have suggested that this
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is a direct effect of ibuprofen on neutrophils rather than
the effect of the drugs on prostaglandin metabolism
(Rampart, 1986). Similarly, the potential role of
superoxide dismutase in preventing production of a free
radical derived chemotactic factor could also be examined.
Such studies could again be undertaken using radiolabelled
neutrophils and sequential gamma camera imaging in
patients with myocardial infarction treated with drugs
such as ibuprofen or superoxide dismutase.
Plasma neutrophil elastase is a marker of neutrophil
activation and the release of lysosomal enzymes from the
primary or azurophilic granules requires major stimulation
of the cell such as phagocytosis or cell death.
Proteolytic enzymes, in particular neutrophil elastase,
have been implicated in the pathogenesis of a number of
disease conditions (Malech, 1987) including myocardial
infarction. It is also known that this enzyme can
directly injure endothelial cells in culture and hence may
be involved in vascular injury. It is therefore
interesting that as a group patients with documented
ischaemic heart disease have mildly elevated levels of
this enzyme. Whether this represents mechanical damage to
neutrophils secondary to pre-existing atheroma rather than
truly reflecting a pathogenetic mechanism is unclear.
The role of elastase in endothelial injury or atheroma
could perhaps be further investigated by using specific
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elastase antibody and immunoperoxidase techniques in
histopathological sections of coronary vessels obtained at
post-mortem or from heart transplant recipients. If
increased levels were found in areas of atheroma compared
to normal areas this would support the suggestion that
elastase contributes to vascular disease (Robert, 1984).
In patients with acute myocardial infarction the levels of
human neutrophil elastase are significantly increased in
the first 48 hours following myocardial infarction
compared to normal subjects or patients with ischaemic
heart disease. This may be thought to be a normal
response to stress. However, this is unlikely as we have
shown that plasma neutrophil elastase does not correlate
with the peripheral neutrophil count which itself
increases as part of the normal stress response. The
pattern of evolution of neutrophil elastase also differs
in patients with myocardial infarction treated with and
without thrombolytic therapy while presumably these
patients are exposed to similar degrees of stress. The
high initial levels of neutrophil elastase in patients
treated with thrombolytic agents suggest intravascular
release whereas the later increase in plasma neutrophil
elastase seen in patients treated without thrombolysis is
consistent with enzyme release from activated neutrophils
present within the area of myocardial necrosis. This
hypothesis could be further investigated by measuring
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neutrophil elastase and creatine kinase in the venous
effluent from the coronary sinus in patients who require
haemodynamic monitoring following myocardial infarction.
It would also be interesting to examine other neutrophil
products, such as lactoferrin, to confirm the sequence of
events seen with elastase and also to relate this to the
presence of inflammatory mediators such as components of
the complement system (Hartmann, 1977).
Free radicals have also been implicated in secondary
myocardial injury (Werns, 1986). The diene conjugated
non-peroxide isomer of linoelic acid is a product of lipid
oxidation and is thought to measure free radical activity
in man (Iversen, 1985). This is the major conjugated
diene in human plasma and is a product of lipid oxidation,
which is felt to be a more useful marker of free radical
activity than other methods which measure the end products
of the normal lipid peroxidation pathway and hence assess
both products of oxidation and peroxidation. Similarly,
some assays of lipid peroxidation such as thiobarbituric
acid are non-specific (Halliwell, 1984) as they also
detect prostaglandins and glycosylated proteins.
The results show that the plasma levels of non-peroxide
diene conjugated isomer of linoelic acid is similar in
patients with stable ischaemic heart disease and normal
subjects. This suggests that lipid oxidation and hence
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free radical activity is not necessarily increased in
patients with atheroma in the absence of tissue ischaemia.
In contrast levels are high in patients with acute
myocardial infarction, peak levels occurring at
approximately 16 hours after the onset of symptoms in
patients treated with or without thrombolysis. As there
was no difference in the levels of PL-9, 11-LA' between
between patients treated with or without thrombolysis this
does not support the experimental evidence which suggests
that increased free radical production is a major
component of reperfusion injury. Also in patients who did
not receive thrombolytic therapy, there was no late
increase in levels of PL-9, 11-LA', similar to that found
with plasma neutrophil elastase (figs 9a and b). Perhaps,
therefore, the release of proteolytic enzyme is the more
important mechanism of secondary tissue injury.
There has been some controversy in the literature over the
use of PL-9, 11-LA' as a marker of free radical activity.
Part of this has arisen because it was felt to be a marker
of cervical cancer (unrelated to free radical production)
(Singer, 1987 ). However, this is now thought to be due
to bacterial colonisation (Green, 1988). Similarly it
has been suggested that increased levels in man may
represent bacterial dehydrogenation of linoleic acid in
the gastrointestinal lumen with subsequent absorption



















































Fig 9a Changes in plasma creatine kinase, plasma
neutrophil elastase and plasma PL-9,11-LA' in
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9b Changes in plasma creatine kinase, plasma
neutrophil elastase and plasma PL-9,11-LA' in
patient treated with intravenous thrombolytic
therapy.
differences between patients with ischaeraic heart disease
or the acute increase seen in patients with myocardial
infarction. It should also be remembered that PL-9, 11-
LA' is the major diene conjugate in human plasma and that
measurement of total diene conjugates is still considered
to reflect increased free radical production (Lunec,
1981). Finally, the levels of linoleic acid which can
also be altered by diet did not differ with time in
patients with myocardial infarction. The answer to the
role of free radicals in myocardial ischaemia will
probably only be answered using technigues to measure free
radicals directly such as electron spin resonance (Mason,
1984).
By producing alterations in cell membranes, lipid
peroxides have themselves been implicated in cell damage
(Meerson, 1984) and it is possible that the non-peroxide
diene conjugated isomer of linoleic acid not only reflects
free radical activity, but also may itself mediate cell
damage. Recent work has confirmed the presence of
another metabolite of linoleic acid (linoleate epoxide),
named leukotoxin, which is generated by neutrophils and
may be the result of a monoxygenation of linoleic acid by
free radicals (Oliw, 1981). Leukotoxin has now been
shown to be a potent mediator of pulmonary damage (Ozawa,
1988 ) and hence could also have a role in secondary
myocardial injury. By measuring leukotoxin and the non-
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peroxide diene conjugated isomer of linoleic acid
simultaneously further information about the source of
oxygen free radicals and mechanism of secondary myocardial
injury may be gained. These measurements could also be
combined with neutrophil elastase to assess the potential
therapeutic effects of drugs such as ibuprofen and free
radical scavengers on neutrophil function in vivo,
following myocardial infarction. Interestingly, it has
also been recently suggested that the angiotensin
converting enzyme inhibitor captopril, because of its
sulphydril group, may also be a free radical scavenger
(Westlin, 1988).
Using the technigues described in this thesis it would be
interesting to study other aspects of ischaemic heart
disease. For instance, does the neutrophil have a role
in unstable angina, perhaps through neutrophil
i
margination, contributing to microvascular occlusion,
with or without neutrophil activation. It would also be
interesting to study the effect of balloon angioplasty of
a coronary vessel on neutrophil activation and free
radical production, as this technique must produce
endothelial damage. If there is a significant
endothelial/neutrophil interaction it should be possible
to detect this by measuring neutrophil elastase, the non-
peroxide diene conjugate of linoleic acid and perhaps
other inflammatory mediators in the coronary sinus
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effluent or peripheral blood.
The studies outlined in this thesis show that there is a
significant acute inflammatory response to mycoardial
infarction, which can be imaged using radiolabelled
autologous neutrophils and that this is associated with
evidence of neutrophil activation. There is also
evidence of increased free radical activity, though the
source of free radical generation remains uncertain.
They suggest that these mechanisms may be important in
secondary myocardial injury. However, the results do not
support, experimental evidence, which suggests that
successful reperfusion is associated with an enhanced
inflammatory response with the associated potential to
produce further damage to already injured myocytes.
Ischaemic heart disease remains the commonest cause of
death in industrialised countries often affecting the
younger age group. Athough the therapeutic benefits of
thrombolytic therapy in terms of mortality and improved
myocardial salvage are now established (GISSI-2, ISIS 2),
this therapy is not suitable for all patients. Estimates
suggest that only 14 to 50% of patients fulfil the current
criteria for thrombolysis (de Bono, 1987). It therefore
seems important to pursue other methods of improving
myocardial salvage as this may still significantly
contribute to reduced mortality. Experimental evidence
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from this and earlier work suggests that the neutrophil
has a role in secondary myocardial injury and it is
interesting to speculate that some of the beneficial
effects of thrombolysis might be related to reducing the
intensity of the acute inflammatory infiltrate, at the
site of myocardial damage. Potential methods to further
study the importance of the neutrophil in myocardial
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TABLE 3 (ii) KINETIC DATA
INDIUM COUNTS FOR EACH ORGAN CORRECTED FOR TIME EXPRESSED AS A
PERCENTAGE OF MAXIMUM WHOLE FIELD OF VIEW COUNTS FOR THE
8 SUBJECTS AT PROGRESSIVELY INCREASING TIME INTERVALS
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255 1.0 2.6 3.2 2.0 1.4 1.4 3.1 2.1
285 1.0 2.6 3.0 1.9 1.5 1.4 3.1 2.0
315 1.1 2.6 3.1 1.9 1.5 1.4 3.1 2.0
345 1.1 2.5 3.1 2.0 1.5 1.3 2.8 1.9
375 1.1 2.5 2.9 1.8 1.6 1.3 3.0 2.0
405 1.0 2.4 2.9 1.7 1.5 1.2 2.9 1.9
435 1.0 2.4 2.9 1.8 1.5 1.2 2.8 1.8
465 1.0 2.5 2.9 2.1 1.5 1.2 2.9 1.7
495 1.0 2.3 2.9 1.8 1.4 1.2 3.0 1.7
525 1.0 2.4 2.9 1.9 1.5 1.3 2.9 1.8
555 1.0 2.3 2.8 1.7 1.4 1.2 2.9 1.7
585 1.0 2.3 2.8 1.8 1.4 1.2 2.8 1.8
630 0.9 2.2 2.9 1.8 1.5 1.2 2.7 1.8
690 1.0 2.3 2.9 1.8 1.4 1.2 3.0 1.8
750 0.9 2.3 2.9 1.7 1.4 1.1 2.7 1.7
810 0.9 2.2 3.0 1.6 1.5 1.1 2.8 1.7
870 1.0 2.2 3.0 1.7 1.5 1.2 2.8 1.7
930 1.0 2.2 3.0 1.7 1.4 1.2 2.7 1.7
990 1.0 2.1 3.0 1.7 1.4 1.2 2.7 1.6
1050 0.9 2.1 3.0 1.6 1.5 1.2 2.7 1.6
1110 0.9 2.1 3.1 1.6 1.5 1.1 2.7 1.6
1170 0.9 1.9 3.1 1.7 1.5 1.2 2.6 1.6
1230 0.9 2.0 3.1 1.7 1.5 1.2 2.7 1.6
1290 1.0 1.9 3.1 1.6 1.4 1.1 2.8 1.6
1350 0.9 1.9 3.2 1.6 1.4 1.2 2.7 1.7




1410 0.9 1.8 3.2 1.6 1.4 1.1 2.8 1.6
1470 0.9 1.8 3.2 1.6 1.4 1.1 2.8 1.7
1529 0.9 1.8 3.2 1.7 1.4 1.1 2.8 1.5
j
TABLE 3 (ii) KINETIC DATA
LUNGS







































































































































































































































TABLE 3 (ii) cont'd
LIVER













































































TABLE 3 (ii) KINETIC DATA
SPLEEN
TIME S B F Mc H M
(sees)
2 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0
7 0.1 0.2 0.3 0.9 0.2 0.3 0.9 0.7
17 0.6 0.8 1.1 3.1 0.8 1.5 2.9 1.5
22 0.7 1.1 1.5 3.3 0.8 1.5 3.2 1.6
27 1.0 1.1 1.5 3.3 1.0 1.8 2.9 1.6
35 1.0 1.3 1.6 3.1 0.9 1.5 3.0 1.8
45 1.0 1.4 1.6 3.8 0.8 1.5 3.0 1.9
55 0.9 1.5 1.8 4.4 0.8 1.7 3.3 2.1
65 1.2 1.8 2.0 4.6 1.0 1.6 3.4 2.3
75 1.2 1.6 2.1 4.8 0.9 1.8 3.5 2.3
85 1.4 2.0 2.2 5.0 1.0 1.8 3.5 2.4
95 1.4 2.2 2.5 5.3 1.0 2.0 3.4 2.2
105 1.3 2.2 2.5 5.5 1.1 2.1 3.6 2.6
115 1.2 2.3 2.6 6.0 1.2 2.1 4.1 2.9
130 1.4 2.5 2.9 6.5 1.2 2.3 3.9 3.0
150 1.5 2.4 3.1 6.8 1.2 2.4 4.0 3.4
170 1.6 2.7 3.4 7.2 1.3 2.4 4.1 3.3
190 1.6 2.8 3.6 7.7 1.0 2.7 4.5 3.5
210 1.6 2.7 3.7 8.5 1.4 2.6 4.6 3.5
230 1.8 2.8 3.9 8.7 1.1 2.7 4.6 3.5
255 2.0 2.9 4.0 8.9 1.4 2.8 5.0 3.9
285 2.0 3.0 4.3 9.4 1.3 2.8 5.3 3.9
315 2.1 3.1 4.6 9.8 1.3 3.0 5.5 4.0
345 2.2 3.1 4.8 10.2 1.3 3.1 5.6 4.3
I
TABLE 3 (ii) cont'd
SPLEEN











































































PATIENTDE AILSNDR SULTSOFIMAG GW THINDIUM-111L BEL EDAU OLOGOUSN UTR P IL Positiveimag (n=23)
Negativeimage (n=7)
Statistical significance
Age(years) Sex Locationfacutemyocardialinf rct Intervalfromnsetfchespaint injectionofl^-Inneu rophils(h) Peakcre tinekinas(u/1) Totalleucocyteunt(10^/1) Numberofneutrophilsinjected(10®/1) Activityofminadmi stered(MBq) Drugsadministered: Non-steroidalanti-inflammatorydrugs Lignocaine Calciumntagonists Nitrates
62.0(10.8) (6F;17M) 10inf;3ant 20.3(6 4) 2023.5(916.0) 12.9(3 2) 2.7(0.9) 32.8(8 4) 5 2 1 7
59.8( 4) (2F;5M) 3inf;4ant 27.6(5 8)
1825(1214.0) 12.5(3 4) 2.6(0.7) 29.4(8 2) 1 3 2 1
NS(1) NS(2) NS(2) p<0.02(3) NS(1) NS(1) NS(1) NS(1)
Allvaluesarshownsmea(SD) (1)Unpairedtest (2)Exactprobabilitytes (3)UnpairedWilcoxonranksumtest


































































































































































LVEF (%) 40 52 35 56 29 42 27 68 24 25 26
TABLEb(ill) SUMMARYOFDET ILSPA IENTSTRE TEDW HNDITHOUTTHROMB LYSISW OREI GEDH BOTH111IN-NEUTROPHILSAND99m CPYROPHOSPHATE CKmaxLVEFTimeto111In99raTclllIn/99mTc u/litre(%)injectionvox ls)( Nothrombolysis25083681142 10.79
(n=10)(522-6255)15-51)4. 14. )( 9 27677 40(0.0 - .14) Thrombolysis25004118170.41 (n=11)(533-6955)27-685 10-1 0)11 -323)( 0.96 NSp<0.05
TABLE 6 (i)
CHARACTERSTICS OF NORMAL SUBJECTS, PATIENTS WITH CHRONIC ISCHAEMIC




IHD NO THROMBOLYSIS THROMBOLYSIS












































TABLE6(ii) STATISTICALRESULTSFORN UTROPHILELASTA ECOMPA INGTHROMBOLYTICNDNO-TH OMBOLYTICTHER PY OVERTIMEWITHCON ROLSUBJ CTS 8hours16243240r8 Nothromb lysisp<0.00061. 0.00 5 Thrombolysisp<0.0001..00010 3 TABLE6(iii) STATISTICALRESULTSFORN UTROPHILELA ASECOMPARINGHR MBOLYTICANDN - HROMBOLYTICHE PY OVERTIMEWITHPATI NTSISCHAEMICHE RTDISEASE 8hours162432408 Nothromb lysisSp<0.012.0550143 Thrombolysisp<0.000120. 4NS
TABLE 7 (i)
ENDOGENOUS ANTIOXIDANT DEFENCE MECHANISMS
ANTIOXIDANT MECHANISM EFFECT ON
LIPID PEROXIDATION
Vitamin C Scavenges free radicals Yes
Vitamin E Scavenges free radicals No
Glutathione peroxidase Catalyses H2O2 to 1^0 Yes
Catalase Catalyses H202 to H20 No
Superoxide disirutase Catalyses 02~ to H202 No
Lactoferrin/
transferrin Bind iron salts Yes
Caeruloplasmin Mechanism not understood Yes
TABLE7(ii)
STATISTICALRESULTSFORPL-9,11-LA'COMPARINGTHROMBOLY ICANDNO THROMBOLYT THERAPYOVERIMEWITHCONTROLSUBJECTS 8hours1624r32hou s40r8
Nothromb lysisp<0.00191130.005717 Thrombolysisp<0.001.000 14. 60 27 TABLE7(iii) STATISTICALRESULTSFORPL-9,11-L 'COMPARINGTHROMBOLYTICANDNO-THR MBOL IC THERAPYOVERIMEWITHPATIENTSISCHA MICHEDIS AS 8hours16hours2432hours408r Nothromb lysisp<0.02.0380 235NS Thrombolysisp<0.00840. 17230.0145NS
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Summary
Using a single step separation procedure, we have developed a method for labelling human
neutrophilswith 11 'In-oxine. Thismethod allows a rapid separation of neutrophils from whole
blood, with negligible mononuclear or red cell contamination. Preliminary studies using
"'In-labelled neutrophils show minimal lung retention and early accumulation in the spleen
consistent with viable cells. In addition, focal accumulation of 1" In has been imaged in patients
with localized inflammation or sepsis.
Introduction
Indium-Ill ('"In) labelled leucocyte imaging has become a common investigation
for the localization of inflammatory lesions [1-5]. The neutrophils are the pre¬
dominant cell involved in the inflammatory response and it has therefore been
suggested that a pure preparation of neutrophils is superior tomixed leucocytes for
in vivo studies using ' "In-labelled cells [6], The use of pure neutrophils also has the
advantage of avoiding the labelling of the radiosensitive lymphocytes [7-9],
A number of methods exist to isolate pure neutrophils from blood but at present
these are time consuming and involve several steps [10, 11]. Mono-poly Resolving
Medium is a commercially available medium which can be used to isolate neutro¬
phils from whole blood in a single step. In this paper we describe the isolation of
neutrophils by this technique and their subsequent labelling with "'In-oxine.
Kinetic data and positive clinical studies are also presented.
0143-3636/86 $03.00+ .12 © 1986 Chapman andllall Ltd.
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Methods
Patients
Investigations with '"In-neutrophils were performed on 45 patients with a variety of sus¬
pected inflammatory clinical conditions. Neutrophil kinetics were studied in eight of the
patients with no evidence of active lung disease.
Cell separation
Venous blood (60 ml) was collected aseptically via a 19G infusion set into a syringe containing
300 units of preservative-free heparin. A full blood count and ESR were performed on 10 ml
blood. All subsequent procedures were performed using aseptic technique. In duplicate, 25ml
blood was layered over 12 ml Mono-poly Resolving Medium (Flow Laboratories) in a sterile
tube and centrifuged at 400 g for 60 min. Differentialmigration during centrifugation results in
two distinct cell bands and a red cell pellet (Fig. 1). From the top plasma layer, 8 ml was
collected and centrifuged at 1000 g for 10 min to provide platelet-poor plasma (PPP). The
remaining plasma and upper cell band containing mononuclear cells were discarded. The
neutrophils were recovered from the lower cell band, resuspended in 40 ml phosphate
buffered saline pH 7.4 (PBS) and centrifuged at 400 g for 10 min. The supernatant was
discarded and the cell pellet was resuspended in 10 ml PBS. A 1 ml sample was taken to









Fig. 1. Diagnostic illustration of blood cell separation on Mono-poly ResolvingMedium.
Labelling procedure
"'In-oxine solution (20-40 MBq) (Amersham International pic) was added dropwise to the
remaining suspension of neutrophils. After incubation at room temperature for 15 min, 3ml of
PPP was added then the cell suspension was centrifuged at 250 g for 10 min. The supernatant
was transferred to a fresh tube. The cell pellet was resuspended to a volume of 5mlwith equal
parts of PBS and PPP. The activities of the cell suspension and supernatantweremeasured in a
radioisotope calibrator and the labelling efficiency calculated. The cell suspension which
contained 18 to 40 MBq '"In and 2.0 to 13.0X107 cells ml-1 was drawn into a syringe ready for
injection.
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Cell counting
All cell counts were performed manually using a new improved Neubauer chamber (0.100
mm). Blood films made from whole blood and the neutrophil suspension were stained with
May-Grunwald/Giemsa and a differential cell count determined. The percentage cell recovery
was calculated by comparing the neutrophil count in whole blood with that in the neutrophil
suspension.
Scintigraphic investigations
Imaging was performed using a large field of view gamma camera (GEC-400T Maxicamera)
interfaced to a PDP11-34 computer (Digital Equipment Corporation). Kinetic data were
obtained from eight patients in the followingmanner: the patient was positioned anteriorly to
visualize lungs, liver, spleen and heart and the ' "In-neutrophil suspension was administered
intravenously by a fast running 5% dextrose infusion. A sequence of 64x64matrix images was
taken over 25 min at a varying frame interval starting at 5 s for the first six images and then
increasing stepwise to 60 s for the later images. The counts were normalized for frame length.
To assess '"In-neutrophil kinetics, the movie images were inspected and regions of interest
(ROI) created around the heart, lungs, liver, spleen and whole field of view. The whole field
frame showing the maximum count-rate was assumed to represent the total activity injected.
The count-rates from the other ROIs were expressed as a percentage of the maximum whole
field count-rate and a time-activity curve was created for each organ. This method of data
analysis allows direct comparison of the relative activity in each organ. In all patients, static
images were obtained at 6 and 24 h after injection.
From the 45 patients' blood samples on which separation was performed, the
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Fig. 2. 1 "In-neutrophil time-activity curves for lungs, heart, liver and spleen.
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Fig. 3. Gamma camera image (24 h) showing the anterior abdominal view obtained from a
patient with ischaemic colitis. Predominant uptake of "'In can be seen in the sigmoid and
descending colon.
Fig. 4. Anterior chest image (24 h) showing marked uptake of "'In in the left upper lobe of a
patient with obstructive pneumonia in the left upper lobe.
Fig. 5. Reconstructed "'In transverse and coronal head images at 24 h obtained using single
photon emission computerized tomography in a patientwith a right frontal cerebral abscess.
1'' In-oxine labelled neutrophils 451
neutrophil count less than 4.2xl07. All neutrophil suspensions were labelled with
1' 'In-oxine and a mean labelling efficiency of 72.1% (s.D.±12.9%) was achieved. In
addition, red cell contamination was calculated in the eight patients used for kinetic
data and was found to be 5.7% (s.D. ±2.6). Lymphocyte contamination was found to
be less than 0.5%.
Fig. 2 shows the mean "'In-neutrophil kinetic data obtained from the eight
patients studied. The data are expressed as percentages of the maximum count rate
achieved in the whole field of view. Heart count-rate falls to 3% of the maximum
whole field count-rate within 90 s and after 5 min remains constant at 2% for the
remainder of the study. Similarly, lung count-rate falls to 19% within the first 90 s
and thereafter falls at a slower rate to 9% by 20min indicating a small degree of lung
retention. The liver count-rate rises to 16% by 15 min and remains constant, whereas
the spleen count-rate continues to rise throughout the study.
Of the 45 studies, 18 showed positive uptake, three examples ofwhich are given in
Figs. 3 to 5. No patientwith a negative scan was subsequently demonstrated to have
a major site of infection.
Discussion
Leucocytes labelled with a variety of radionuclides have been used to locate infection
or inflammation since the early 1970s [12-14]. In recent years, '"In-chelates have
been used to label leucocytes for routine diagnostic purposes. While much of the
initial work has involved the labelling of mixed leucocytes with 1 "In, more recently
emphasis has been placed on two advantages of using pure neutrophils: (1)
avoidance of labelling radiosensitive lymphocytes [7-9]. (2) Reduction in the
labelling of non-specific cells principally erythrocytes and platelets [6],
A number of techniques have been developed to isolate and label pure neutrophils
with '"In. These methods are time consuming, requiring the preparation of a
discontinuous density gradient for the cell separation. In an attempt to retain cell
function it has been recommended that the neutrophils be isolated and labelled in a
plasma environment. To achieve this, a technique using a discontinuous density
gradient prepared with the patient's own plasma and subsequent labelling in plasma
with "'In-tropolonate has been developed [10]. Isolation and labelling in this
manner does, however, prolong the procedure as the gradient can only be prepared
after cell-free plasma has been obtained.
The purpose of this study was not to evaluate the efficacy of ' "In-labelled neutro¬
phils as a diagnostic tool as this has been well documented, but to describe a
technique for isolating neutrophils directly from whole blood without the need to
perform an initial sedimentation step using dextran, hydroxyethyl starch ormethyl
cellulose as is the current practice [7, 10, 11]. Subsequent labelling of the separated
pure neutrophils is achieved with '"In-oxinate. This method does not require the
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preparation of a discontinuous density gradient but uses the commercially available
Mono-poly Resolving Medium. Good neutrophil recovery is achieved with little red
cell and virtually no lymphocyte contamination. Labelling efficiency is excellent and
agrees well with other published data for 11 'In-oxinate [2,11,15,16].
A number of studies has shown that poorly functioning or damaged 11 'In-labelled
neutrophils demonstrate lung retention or liver sequestration [2, 17-20]. It is
essential that11 'In-labelled cells prepared by any new techniques of cell isolation be
assessed for lung retention. One method of achieving this is to compare the passage
through the lungs of a simultaneously injected ""Tcm-red blood cells and "'In-
neutrophils with simultaneous acquisition in the two energy windows [15]. Using
this technique the "!'Tcm activity-time curve represents blood flow through the
lungs. Retention of '"In-neutrophils is therefore demonstrated by the difference in
the lung time-activity curves for the two radionuclides. We decided to use a simpler
technique, comparing the "'In activity-time curves for the lungs and heart, the
difference in the slope of the two curves demonstrating lung retention. Kinetic data
obtained from eight patients in this manner demonstrated early uptake in the
liver and spleen, with splenic activity continuing to rise throughout the period of
study consistent with functioning cells. Lung clearance of the "'In-labelled neutro¬
phils occurs rapidly, 80% clearing within 90 s. When the lung and heart clearance
curves are compared, retention of "'In in the lungs is seen, consistent with the
margination of neutrophils within the pulmonary vasculature. Evidence of retention
is minimal by 20 min. The difference in total lung and heart counts at 25 min can
largely be explained on the basis of differences in pulmonary and cardiac blood
volume and need not represent continuing lung retention of '"In-labelled neutro¬
phils. This corresponds well with the kinetic data reported in previous studies [15,
20], showing little lung hold-up with rapid pooling of neutrophils within the spleen.
Further confirmation that the cells are functionally viable is provided by the positive
scans obtained from a group of patients with a variety of infective and inflammatory
conditions, examples of which are given earlier.
In conclusion, we have demonstrated a rapid single-step separation procedure for
the isolation of pure neutrophils from whole blood using Mono-poly Resolving
Medium. This method is rapid and involves less handling of cells, thus reducing the
risk of mechanical damage and requiring less technical expertise. Pure neutrophils
separated by this technique have good in vivo kinetics and appear functionally
normal.
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rtARY The uptake of indium-Ill labelled neutrophils was examined in 30 patients with
; myocardial infarction by planar imaging and single photon emission computed tomo-
hy. The time from venepuncture to reinjection of the autologous labelled neutrophils was
> hours and imaging was carried out 24 hours later. Twenty three patients had a positive
ke of neutrophils in the myocardium and imaging was improved by single photon emission
juted tomography. There was a significant difference between the intervals from the onset of
: pain to injection of labelled neutrophils between patients with positive and negative images;
reinjection was more likely to produce a positive image. Indeed, all nine patients reinjected
in 18 hours of the onset of symptoms had positive images.
le results suggest that the stimulus for activation and migration of neutrophils is transient;
s an important factor if neutrophil release products play a role in cell damage after coronary
ision.
myocardial infarction, myocardial cell death
damage produce an acute inflammatory
nse characterised by the migration of neutro-
into the area of infarcted muscle. Histological
ination shows neutrophil infiltration into the
:ted area within 24 hours and the response is
nal at 4-5 days.1 2 As part of the inflammatory
nse, neutrophils release oxygen derived free
lis and proteolytic enzymes that in certain cir-
tances may increase tissue injury. To date, the
ophil has been implicated in damage to pul-
ry capillaries in adult respiratory distress syn-
e and may also contribute to the pathogenesis
physema. No definite role has been established
e neutrophil extending myocardial damage in
but in animal models ofmyocardial infarction,
t size can be limited by neutrophil
tion.3 4
hough experimental studies have shown
e of indium- 111 (111 In) labelled neutrophils in
ted myocardium5 6 studies in man have pro-
1 conflicting results. McDougall etal did not
;ts for reprints to Dr D Bell, Department of Medicine, Royal
iry, Edinburgh EH3 9YW.
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detect uptake of labelled cells in three patients with
acute infarction.7 The time of injection of labelled
cells may be of importance, however, because
Davies and colleagues obtained positive images
when the time to reinjection was short.8 They also
found that positive images were more likely in
younger patients.
We have used 111 In labelled autologous
neutrophils in 24 patients with acute myocardial
infarction. Our results confirm the importance of
early injection of the neutrophils in obtaining a posi¬
tive image. We also found that reconstructional
imaging from single emission photon computed
tomography can be used to resolve difficulties in the
interpretation of planar imaging.
Patients and methods
PATIENTS
We studied 30 patients with a diagnosis of acute
myocardial infarction based on a history of pro¬
longed ischaemic chest pain (> 30 minutes), electro¬
cardiographic changes associated with myocardial
infarction, and a rise in serum creatine kinase to at
least twice the upper limit of normal. All gave




our institute's ethical committee. Table 1 shows
patient details and a full record of the drugs admin¬
istered within the first 24 hours of myocardial
infarction. " : 'VV ■ "
PREPARATION OF U1IN LABELLED
NEUTROPHILS
Autologous neutrophils were separated from whole
venous blood and labelled with '"In-oxine.9 We
used an aseptic technique to withdraw whole blood
(60 ml) into a syringe containing 300 units of pre¬
servative free heparin. Duplicate samples (25 ml) of
blood were layered over 12 ml of mono-poly
resolving medium (Flow laboratories) in a sterile
tube and centrifuged at 400 £ for 60 minutes. This
produced a top plasma layer, two distinct cell bands,
and a red cell pellet. We collected 8ml from the top
plasma layer and centrifuged it at 1000£ for 10
minutes to obtain platelet poor plasma. The remain¬
ing plasma and upper cell band were discarded and
the neutrophils were recovered from the lower cell
band. The neutrophils were washed by diluting the
recovered cell suspension to 40ml with phosphate
buffered saline pH 7-4, centrifuging at 400g for 10
minutes, and discarding the supernatant. The cell
pellet was resuspended in 10ml phosphate buffered
saline and 1 ml of 1" In-oxine solution (20-40MBq)
was added drop by drop to the suspension of neu¬
trophils. After incubation at room temperature for
15 minutes, 3 ml platelet poor plasma was added and
the cell suspension was centrifuged at 250^ for 10
minutes. The supernatant was discarded, the neu¬
trophil cell pellet was resuspended to a total volume
of 5ml with equal parts of phosphate buffered saline
and platelet poor plasma and the labelled cells were
then ready for reinjection.
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PATIENT IMAGING
All patients were injected at a fresh site with 11'
labelled autologous neutrophils within two and
half .hours'of the initial venesection. Prelimina
studies had suggested that the optimal time 1
imaging was 24 hours after the injection of labell
neutrophils and we used this imaging time in all o
patients. Thus the earliest imaging time for a
patient was 36 hours after the onset of chest pain a
the latest was 57 hours. Each patient was imag
while supine and planar images were acquired in I
anterior, left anterior oblique, and left lateral po
tion for 100000 counts with a gamma cam'
(GE400AT). In 24 patients single photon emissi
computed tomography was performed with the sa
gamma camera linked to a DEC PDP11/23+ co
puter that used locally written software. 1
minutes before the single photon emiss
computed tomography study, 40MBq
technetium-99 m (99mTc) human serum albur
was administered to allow blood pool imaging
sequence of 64 simultaneous images of 4<,mTc ;
"1 In was then acquired as the head of the gam
camera rotated through 180°, starting in the ri
anterior oblique position. The total imaging ti
was 32 minutes. At the end of this pet
computerised reconstruction of the images '
performed.
IMAGE INTERPRETATION
An observer who was unaware of elec
cardiography findings or the maximum crea
kinase rise graded planar and single photon emis
computed tomography images as positive (in wl
indium activity was clearly seen in the region oi
heart) or negative (where there was no detect
Table 1 Patient details and results of imaging with indium-111 labelled autologous neutrophils
Positive image Negative image Statistical
(n = 23) (n = 7) significance
Age (years) 62 0 (10-8) 59-8 (9 4) NS (1)
Sex (6F; 17M) (2F; 5M) NS (2)
Location of acute myocardial
infarct 10 inf: 13 ant 3 inf: 4 ant NS (2)
Interval from onset of chest pain to
injection of 1,1 In neutrophils (h) 20-3 (6-4) 27-6 (5-8) p < 0 02 (3)
Peak creatine kinase (u/I) 2023-5 (916-0) 1825 (1214-0) NS (1)
Total leucocyte count (109/1) 12 9 (3-2) 12 5 (3-4) NS (1)
Number of neutrophils injected ( x 10H) 2-7 (0-9) 2-6 (0-7) NS (1)
Activity of 111 In administered (MBq) 32-8 (8-4) 29-4 (8-2) NS (1)
Drugs administered:
Non-steroidal anti-inflammatory drugs 5 1
Lignocaine 2 3
Calcium antagonists 1 2
Nitrates 7 1
All values are shown as mean (SD).
(1) Unpaired i test.
(2) Exact probability test.
(3) Unpaired Wilcoxon rank sum test.
I
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activity or where there was an area of activity on
planar imaging that was inseparable from the liver,
spleen, or ribs). Dual isotope single photon emission
computed tomography images were considered to be
positive when indium activity was seen in all three
reconstruction views and corresponded with the
99n,Tc blood pool image.
STATISTICAL ANALYSIS
Data from the groups were compared by means of an
unpaired t test, exact probability test, or unpaired
Wilcoxon rank sum test as appropriate. Values of
p > 0 05 were regarded as not significant.
Results
In 23 of the 30 patients with acute myocardial
infarction there was uptake of "'In labelled
neutrophils within the myocardium. Three patterns
of cardiac uptake were seen5: focal myocardial
uptake (12 patients), diffuse myocardial uptake (3
patients), and "doughnut pattern" (3 patients).
Figure 1 shows an example of myocardial uptake.
Planar images from all patients were graded as
unequivocally positive or negative. In six patients in
whom the planar images were considered to be nega¬
tive, single photon emission computed tomography
reconstruction showed localised uptake within the
myocardium (fig 2). In addition, dual isotope single
photon emission computed tomography recon¬
struction improved anatomical localisation of the
infarct by confirming uptake corresponding to the
cardiac blood pool (fig 3). There is a significant
difference between the intervals from onset of chest
pain to injection of labelled neutrophils in the
groups with positive and negative images (p < 0 02)
(table 1). Furthermore, all patients reinjected within
18 hours had positive images whereas positive
images were increasingly less common in those
injected at progressively later intervals. Other
features such as age, sex, peak creatine kinase,
peripheral white blood cell count, dose of '"In
administered, and drug treatment did not influence
the imaging results (table 1).
Discussion
This study confirms that '" In labelled autologous
neutrophils can be used to image the inflammatory
response to acute myocardial infarction in man. The
increased frequency of positive images in this study
(77"„ compared with the 58"„ as previously
described8) is in part related to earlier reinjection of
'"In labelled neutrophils after the onset of chest
pain. This suggests that the stimulus for activation
and migration of neutrophils to the area of myo¬
cardial damage is transient. This temporal relation
may be of particular relevance because of the current
interest in reducing the extent ofmyocardial damage
after myocardial ischaemia or infarction by the use
of intravenous thrombolytic treatment10" or the
potential for the administration of lipoxygenase or
cycloxygenase inhibitors.3
Thrombolytic treatment can produce coronary
reperfusion and hence it could improve myocardial
salvage, but it may result in other events which in
themselves are potentially harmful.'2 In particular,
if the inflammatory response is exaggerated as a
Spleen
Liver
1* ig 1 Planar image in the left anterior oblique view
showing normal uptake of 111 In labelled neutrophils in the
liver and spleen and diffuse uptake in the region of the heart
with an area offocal uptake in the inferior wall of the left
ventricle. The line drawing shows the areas of uptake.
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Fig 2 Anterior planar image with normal uptake in liver
and spleen and no definite myocardial uptake (lop). Single
photon emission computed tomographic image (bottom) in the
transverse plane showing uptake within liver and spleen and
an area offocal myocardial uptake (arrowed).
result of neutrophils entering ischaemic tissue in
greater numbers after reperfusion, the activated
neutrophils could generate a number of cytotoxic
products including oxygen derived free radicals and
proteolytic enzymes, which can extend myocardial
damage.13 Both neutrophil depletion and the use of
Table 2 Imaging results
Fig 3 Simultaneous single photon emission computed
tomographic images in the transverse plane. The 99mTc image
shows blood pool in the left and right ventricle. The
corresponding "1 In image shows extensive uptake within the
myocardium of both ventricles.
non-steroidal anti-inflammatory drugs have been
shown to reduce infarct size in experimental myo¬
cardial infarction,3 4 and these findings may indicate
further potential methods of improving myocardial
salvage in the post-infarct period.
Single photon emission computed tomography
increased the number of positive images by allowing
spatial separation of positive myocardial uptake of
indium from adjacent bone, liver, and spleen. It is
not possible to ascertain from the planar images
whether the 111 In activity detected in the region of
the heart is due to blood pool activity. Dual isotope
single photon emission computed tomography with
99mTc human serum albumin as a marker of blood
pool, however, unequivocally demonstrated that the
"'In activity was localised in the myocardium.
Single photon emission computed tomography, like
pyrophosphate scans,14 may also provide a method
of quantifying neutrophil uptake within the myo¬
cardium.
Imaging with 111 In labelled autologous neutro¬
phils in patients with acute myocardial infarction
allows us to image the acute inflammatory response
to myocardial damage, but should not be regarded as
a technique for the diagnosis or localisation of acute
myocardial infarction because other techniques are
currently more successful. If inhibition of neutro¬
phil migration limits the extent of myocardial
Positive images
Number of Planar positive Planar negative
Time (h) patients SPECT positive SPECT positive Positive images %
18 9 7 2 100
18-24 12 7 3 83
24-36 9 3 1 44
SPECT, single photon emission computed tomography.
Imaging the acute inflammatory response to myocardial
infarction this method can be used to monitor the
temporal relation and extent of neutrophil uptake in
acute infarction.
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The use of111 In-labelled autologous neutrophils
in imaging myocardial infarction
A.J. MUIR, D. BELL, M. JACKSON, J.J. NICOLLand
A.M. MILLAR
Department ofMedicine and Medical Physics, Royal Infirmary, Edinburgh EH3 9Y\N, Scotland
Following myocardial infarction there is an acute inflammatory response, characterized
by the migration of neutrophils into the area of infarcted muscle. Histological examina¬
tion shows neutrophil infiltration into the infarcted area within 24 h and the response
appears to be maximal at about 4 days [1], Although neutrophil infiltration is part of the
normal inflammatory response, in certain circumstances itmight promote further auto-
lytic changes. Neutrophils, when activated, can release oxygen-derived free radicals
and proteolytic enzymes that may increase tissue injury, and the neutrophil has been
implicated in a number of disease processes, including emphysema, the adult respirat¬
ory distress syndrome and even rheumatoid arthritis. A number of animal models of
myocardial infarction have shown that infarct size can be limited by neutrophil inhibi¬
tion [2, 3]. There is no evidence whether the neutrophil extends myocardial damage in
man. Reperfusion increases neutrophil influx at the site of tissue injury with
susbsequent activation which can disrupt the cell membranes leading to cell death. At
the same time complement (C5a) is activated and this amplifies the neutrophil response
which may cause local plugging of capillary tissue with neutrophils leading to further
local tissue ischaemia and oedema. The introduction of thrombolytic therapy to reopen
occluded coronary arteries has led to increased speculation about whether the advan¬
tages of revascularization might be partly offset by the disadvantages of revasculariza¬
tion injury.
To explore further the role of the neutrophils in the acute inflammatory response to
myocardial infarction we have used indium-labelled autologous neutrophils. Although
a number of methods existed to isolate pure neutrophils from blood, they were often
time consuming and involved several steps. Usingmonopoly resolving medium we can
isolate neutrophils from whole blood in a single step and, having proved the viability of
this preparation, we can then examine its use in acute myocardial infarction [4],
0143-3636188 $03.00+.12 © 1988 Chapman and Hall ltd.
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Methods
Cell separation and labelling procedures
Venous blood was collected aseptically into a syringe containing 300 units of preservative-free
heparin. In duplicate, 25 ml of blood was layered over 12 ml of monopoly resolving medium
(Flow laboratories) in a sterile tube and centrifuged at 400 g for 60 min. Differentialmigration dur¬
ing centrifugation results in two distinct cell bands and a red cell pellet. From the top plasma layer
8 ml was collected and centrifuged at lOOOg for 10 min to provide platelet-poor plasma (PPP). The
remaining plasma and the upper cell band containing mononuclear cells were discarded. The
neutrophils were recovered from the lower cell band and resuspended in 40 ml of phosphate-
buffered saline (pH 7.4) and then centrifuged at 400g for 10 min. The supernatant was discarded
and the cell pellet was resuspended in 10 ml of the buffered saline. nlIn oxine solution (20-40 MBq)
(Amersham International pic) was added dropwise to the suspension of neutrophils. After incu¬
bation at room temperature for 15 min, 3 ml of PPP was added and the cell suspension was centri¬
fuged at 250 g for 10 min. The cell pellet was then resuspended to a volume of 5 ml with equal
parts of phosphate-buffered saline and PPP.
Validation of labelling procedure
From 45 patients blood samples were taken in which separation was performed; neutrophil
recovery was 47% and labelling efficiency was 72%. Red cell contamination was approximately
6% and lymphocyte contamination was less than 0.5%. In eight patients without heart or lung
disease, kinetic data showed that lung count rates fell to 19% of the maximum whole field count
rate within the first 90 s and thereafter fell at a lower rate to 9% by 20 min, indicating only a small
degree of lung retention. Heart count rates fell to 3% of the maximum whole field count rate
within 90 s and remained constant at 2% for the remainder of the study. Liver count rates rose
to 16% by 15 min and remained constant for the rest of the study period whilst splenic counts
continued to rise slowly throughout the study. Of 45 patients studied with suspected occult
infection, 18 showed a positive uptake. No patient with a negative scan was subsequently
demonstrated to have a major site of infection.
Imaging and myocaridal infarction
We examined 30 patientswho had sustained a recent acutemyocardial infarction [5]. The location
of the acute myocardial infarction was inferior in 13 and anterior in 17. All patients were reinjected
at a fresh site with "'In-labelled autologous neutrophils within 2.5 h of the initial venesection.
The time from onset of symptoms to reinjection was noted. Imaging took place 6 and 24 h after
reinjection of the labelled neutrophils. The 24 h images proved superior to those taken at 6 h and
we have therefore used the 24 h images for data analysis. Thus the earliest 'imaging time' for any
patient was 36 h after the onset of chest pain and the latest 57 h. Each patient was imaged while
supine, and planar images were acquired in the anterior, left anterior oblique and left lateral pos¬
ition from 100000 counts with a gamma camera (GE 400 AT). In 24 patients single photon emis¬
sion computed tomography was performed with the same camera linked to a DEC PDP11/23 plus
computer using locally written software. Ten minutes before the single photon emission com¬
puted tomography study, 40 MBq of "Tcm-labelled human serum albumin was administered to
allow blood pool imaging for accurate anatomical location. A sequence of 64 simultaneous images
of "Tcm andmIn was then acquired as the head of the gamma camera rotated through 180°, start¬
ing in the right anterior oblique position. The total imaging time was 32 min.
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Fig. 1. Anterior planar image illustrating uptake of indium-labelled neutrophils in liver, spleen
and myocardium. This patient had sustained a recent anterior myocardial infarction.
Results
In 23 of the 30 patients with acute myocardial infarction there was uptake of111 In-labelled
neutrophils within the myocardium (Fig. 1). In six patients in whom the planar images
were considered to be negative, single photon emission computed tomography recon¬
struction showed localized uptake within the myocardium. The peak creatine kinase
activity, the total leucocyte count, the number of neutrophils reinjected and the activity
of11'in administered all had no influence on whether there was a positive or negative
image. In the same way there seemed to be no relation between the drugs the patient
was receiving and the uptake or lack of uptake of neutrophils in the infarcted myocar¬
dium. The only factor we could determine that influenced the uptake of neutrophils
was the time from the onset of chest pain (Fig. 2). All patients reinjected within 18 h had
positive images, whereas positive images were increasingly less common in those injected
at progressively later intervals.
Discussion
These studies confirm that a pure population of neutrophils can be isolated from whole
blood without the need to perform an initial sedimentation step using dextran, hy-
droxyethylstarch or methylcellulose as is often used. Subsequent labelling of the sepa¬
rated pure neutrophils is achieved with inIn oxinate. Our method does not require the










Fig. 2. The incidence of positive imaging with indium-labelled neutrophils after acute myocardial
infarction. Where labelling and reinjection took place within 18 h of the onset of symptoms, all
patients had a positive image, 10 of the 12 had positive images if reinjection took place within 24
h, but only four of nine had positive images where reinjection took place more than 24 h after the
onset of symptoms.
preparation of a discontinuous density gradient but uses the commercially available
monopoly resolving medium. Good neutrophil recovery is achieved with little red cell
and virtually no lymphocyte contamination. There is no evidence of lung retention or
liver sequestration of these labelled cells, and, as they identify sites of infection, they
appear to be functionally normal.
Using these autologous labelled neutrophils we have demonstrated the inflamma¬
tory response to acute myocardial infarction in man. The increased frequency of posi¬
tive images in our study (77% compared with the 58% previously described by Davies
and colleagues [6]) seem to relate to the early reinjection of the labelled neutrophils after
the onset of chest pain. We would suggest that the stimulus for activation and migra¬
tion of neutrophils to the area of myocardial damage is early. This must be contrasted
with the evidence from pathological studies where neutrophil infiltration appears to be
maximum 2-4 days after the onset of symptoms.
Neutrophil depletion and the inhibition of the inflammatory response have been
shown to reduce infarct size in experimental myocardial infarction, and our results
suggest that, if modulation of the inflammatory response is to be undertaken in man,
this technique is capable of identifying alterations in neutrophil uptake. Imaging with
111 In-labelled autologous neutrophils in patients with acute myocardial infarction allows a
study of the acute inflammatory response to myocardial damage, but should not be
regarded as a technique for the diagnosis or localization of acute myocardial infarction
because other techniques are currently more successful.
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